rfhg_126175.1

Basic information about the TSS

---

TSS ID: rfhg_126175.1 Species: human Chr: chr10		Start: 68338521 End: 68338525 Strand: +
Source datasets	ENCODE
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC004511:142 GeneID: 3189 HGNC/MGI_ID: HGNC:5043 UniProt_ID: Nearer transcript ids and distances: ENST00000490442.5:-181 AF132363:-181 ENST00000478698.1:281 AF132364:429 view more...

Gene_name: heterogeneous nuclear ribonucleoprotein H3 Gene_symbol: HNRNPH3 Gene_synonyms: 2H9 Gene_source: HGNC:5043

TATA-Box annotation

---

Distance to TSS:	-5595
Nearest PromoterID:	NM_001033083
Entrez ID:	64081
Nearest Unigene:	Hs.198158
Nearest Refseq:	NM_022129
Nearest Ensembl:	ENSG00000108187
Gene Name:	heterogeneous nuclear ribonucleoprotein H3
Gene Alias:	HEL-S-306|MAWBP|MAWDBP
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.200000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@HNRNPH3 p2@HNRNPH3 p3@HNRNPH3 p4@HNRNPH3 p5@HNRNPH3 p6@HNRNPH3 p9@HNRNPH3
Sample		p1@HNRNPH3	p2@HNRNPH3	p3@HNRNPH3	p4@HNRNPH3	p5@HNRNPH3	p6@HNRNPH3	p9@HNRNPH3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	238.05	23.57	1.56	1.36	0.39	0.19	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	253.50	20.64	0.81	1.42	0.61	1.82	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	271.42	24.88	1.74	1.74	1.74	1.35	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	216.85	17.46	1.25	0.83	0.21	1.04	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	242.06	25.65	0.90	0.90	1.12	1.57	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	232.18	24.03	1.16	0.39	0.58	0.19	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	280.42	24.19	2.18	1.96	1.74	0.65	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	283.40	25.43	0.97	1.70	0.73	1.45	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	218.63	22.44	1.07	0.85	0.21	0.85	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	418.49	41.73	0.00	1.16	0.00	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	346.83	29.51	1.21	1.21	0.40	2.02	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	358.17	30.49	0.41	0.41	0.00	0.00	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	50.61	5.32	0.81	0.48	0.00	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	52.17	5.56	1.35	0.60	0.15	0.15	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	65.87	6.59	1.10	0.22	0.66	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	44.77	6.29	0.75	0.25	0.25	0.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	44.77	2.40	1.09	0.22	0.22	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	40.49	4.22	1.27	0.84	1.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	54.38	4.27	0.00	0.00	0.53	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	51.15	6.62	0.45	0.30	0.30	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	57.34	6.95	0.27	0.40	0.00	0.13	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	63.01	7.77	0.69	0.00	0.00	0.86	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	54.16	7.24	0.39	0.52	0.52	0.26	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	50.72	7.04	0.24	0.24	0.73	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	58.82	3.87	0.00	0.00	0.00	0.00	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	69.32	9.50	0.63	0.63	0.32	0.32	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	62.09	4.40	0.00	1.10	0.55	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	67.43	7.07	0.24	0.00	0.94	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	52.50	6.62	0.81	0.32	0.32	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	58.63	8.51	0.18	0.00	0.72	0.36	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	62.38	5.65	0.63	0.63	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	57.05	5.08	0.78	0.20	0.00	0.39	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	59.30	4.85	0.63	0.00	0.42	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	81.15	9.90	0.82	0.16	0.33	0.16	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	60.40	6.54	1.12	0.37	0.56	0.75	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	50.97	7.66	0.57	0.57	0.19	0.57	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	53.96	5.93	1.23	0.61	0.41	0.61	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	49.77	6.25	0.60	0.20	0.00	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	84.54	13.24	0.81	0.00	0.54	0.81	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	88.10	10.80	0.48	0.48	0.48	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	47.29	5.41	0.71	1.18	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	68.07	8.20	0.59	0.15	0.15	0.15	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	57.78	2.95	0.84	0.21	0.63	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	47.55	4.55	0.70	0.52	0.17	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	75.89	9.24	1.00	0.40	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	78.63	10.00	1.63	0.70	1.16	0.70	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	47.74	5.28	0.24	0.48	0.24	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	71.53	7.45	0.30	0.00	0.60	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	47.40	4.55	0.00	0.48	0.00	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	53.78	6.67	0.81	0.40	0.20	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	63.54	5.53	0.20	0.41	0.20	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	64.27	5.11	0.00	0.44	0.00	0.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	1539.14	181.90	27.98	41.98	0.00	41.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	35.49	4.61	0.35	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	54.68	3.98	0.00	0.00	0.66	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	382.56	36.91	7.55	5.03	2.52	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	110.68	13.78	0.46	0.92	0.00	0.46	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	43.43	5.83	0.00	0.00	0.65	0.32	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	37.26	3.85	0.32	0.00	0.64	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	104.67	10.37	0.00	1.26	0.63	1.57	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	35.96	2.12	0.00	0.71	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	49.35	6.73	0.56	0.00	0.00	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	175.15	16.72	3.98	4.78	1.59	5.57	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	95.47	8.83	0.68	0.68	0.34	0.68	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	44.84	3.25	0.00	0.32	0.32	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	44.37	6.03	0.35	0.35	1.06	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	1858.85	242.46	48.49	64.66	48.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	1705.86	323.80	23.69	63.18	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	58.99	4.88	0.00	0.49	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	70.41	5.95	0.00	0.00	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	65.21	6.57	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	89.75	10.93	0.66	0.66	0.00	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	60.32	9.59	0.00	0.00	0.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	55.03	8.87	0.00	0.92	0.61	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	119.74	9.03	0.48	0.48	0.16	0.16	0.16
Adipocyte - breast, donor2	11327-117E4	78.45	10.75	3.69	3.21	0.64	2.09	0.16
Adipocyte - omental, donor1	11473-119C6	142.24	10.56	0.89	0.76	0.38	0.38	0.13
Adipocyte - omental, donor2	11474-119C7	82.22	10.46	3.74	1.49	0.00	1.49	0.00
Adipocyte - omental, donor3	11475-119C8	74.35	12.73	1.00	0.33	0.67	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	82.94	8.93	1.28	0.00	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	43.98	5.50	1.10	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	102.07	9.48	0.45	0.00	0.45	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	24.50	2.78	1.56	0.17	0.17	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	134.16	18.77	0.98	0.20	0.00	0.78	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	139.24	14.41	0.51	0.77	0.26	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	108.16	12.82	0.56	0.00	0.00	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	171.64	12.34	0.59	0.00	1.18	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	115.18	15.28	0.24	0.24	0.24	0.00	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	135.23	10.33	1.61	0.65	0.32	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	110.90	10.66	1.60	0.53	0.00	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	127.98	11.69	2.23	0.00	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	59.89	4.99	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	83.89	8.54	0.75	0.00	0.50	0.75	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	77.56	5.24	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	82.82	6.70	1.83	0.00	0.00	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	83.98	6.85	0.22	0.22	0.22	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	16.49	2.51	0.72	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	9.58	2.40	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	68.18	7.20	0.18	0.00	0.18	0.18	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	26.78	3.35	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	24.65	6.57	0.62	0.00	0.00	0.00	0.21
Anulus Pulposus Cell, donor1	11248-116E6	109.85	10.64	0.46	0.46	0.23	0.34	0.00
Anulus Pulposus Cell, donor2	11463-119B5	41.14	3.92	1.47	0.73	0.24	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	53.02	8.54	1.80	0.45	0.00	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	55.14	8.25	4.34	0.43	0.00	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	40.66	0.00	0.00	0.00	4.28	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	60.08	8.97	2.39	1.49	1.20	1.20	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	48.06	11.38	5.06	2.53	1.26	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	46.86	2.64	0.66	0.66	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	43.53	7.47	0.32	0.65	0.97	0.97	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	49.03	8.74	0.49	0.00	0.00	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	52.86	2.97	1.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	60.26	10.17	1.88	0.75	0.38	1.51	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	60.23	7.98	2.18	0.73	0.73	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	22.57	3.76	1.25	0.00	0.00	1.25	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	71.33	6.42	0.33	0.33	0.33	0.16	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	43.67	4.09	2.73	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	55.94	6.03	0.30	0.30	0.60	0.30	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	45.54	8.57	0.54	2.68	0.00	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	47.80	6.80	1.13	0.38	0.00	0.76	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	59.87	6.41	1.07	1.07	1.07	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	46.82	8.78	0.00	0.98	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	44.45	8.13	1.33	0.50	0.50	0.66	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	40.82	7.20	0.00	1.20	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	35.40	0.00	3.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	44.43	5.83	1.03	0.51	0.51	0.51	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	46.14	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	42.23	8.25	2.43	0.00	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	65.27	4.93	2.28	0.00	0.76	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	50.88	2.42	2.42	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	46.74	8.55	0.57	0.00	0.57	0.57	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	45.75	6.20	2.14	0.00	0.21	0.43	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	35.10	3.61	1.03	0.77	0.77	0.26	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	37.07	5.16	2.35	0.00	0.47	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	52.09	7.40	2.25	0.32	0.64	0.96	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	39.24	4.99	0.71	0.71	1.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	50.31	8.77	1.75	1.17	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	53.29	5.72	0.90	0.30	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	38.02	4.75	1.19	0.00	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	56.45	9.15	4.07	1.02	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	63.16	8.91	2.55	1.02	0.76	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	34.31	5.08	0.00	0.00	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	50.06	9.49	3.02	1.73	0.43	0.00	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	49.32	7.62	0.85	0.64	0.00	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	40.02	5.51	0.29	0.29	0.29	0.29	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	34.96	6.61	0.94	1.89	0.00	0.00	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	48.48	6.27	0.51	0.17	0.17	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	37.06	6.95	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	50.70	4.23	4.23	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	50.17	7.93	1.29	0.21	0.21	0.43	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	57.76	3.61	0.00	0.00	0.00	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	33.53	5.10	0.73	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	55.17	7.59	1.15	0.46	0.46	0.92	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	66.31	5.10	7.65	5.10	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	66.35	5.85	0.00	0.76	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	47.48	5.78	1.24	0.00	0.21	0.83	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	41.62	2.75	1.22	1.53	0.31	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	51.63	8.13	0.96	1.91	1.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	49.23	7.98	1.11	0.89	0.22	0.67	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	48.83	3.05	3.05	0.00	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	41.54	3.32	1.11	0.00	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	45.28	8.74	1.32	1.32	0.79	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	43.98	5.09	2.54	0.36	1.09	1.09	0.00
Astrocyte - cerebellum, donor1	11500-119F6	113.97	10.19	0.37	0.25	0.00	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	34.06	7.19	0.34	0.34	0.00	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	23.70	3.78	0.63	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	233.90	27.19	2.79	1.39	0.35	1.05	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	222.12	32.52	6.15	4.04	1.62	2.75	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	198.08	30.28	4.03	1.49	1.49	0.89	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	261.83	51.38	5.50	5.16	2.29	3.10	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	282.89	50.61	5.51	3.38	0.88	1.88	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	304.97	50.18	4.21	3.87	1.25	1.14	0.23
Basophils, donor1	12241-129G9	129.46	7.32	0.52	0.00	0.00	0.00	0.00
Basophils, donor2	12242-129H1	389.30	29.22	0.72	1.44	1.08	0.00	0.00
Basophils, donor3	12243-129H2	125.68	18.08	0.15	1.32	0.00	0.29	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	27.60	3.67	0.22	0.22	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	11.89	4.57	0.46	0.00	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	121.95	0.00	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	45.82	9.41	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	30.36	6.03	0.42	0.21	0.42	0.42	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	31.55	4.61	0.23	0.23	0.46	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	107.61	8.46	1.98	1.80	1.44	2.16	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	458.29	42.15	1.55	1.96	1.03	1.34	0.41
Burkitt's lymphoma cell line:RAJI	10476-106I8	363.56	35.87	3.73	2.33	0.93	1.16	1.16
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	237.91	25.90	1.60	0.96	0.32	0.00	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	392.99	82.74	0.00	0.00	0.00	0.00	10.34
CD14+ Monocytes, donor1	11224-116B9	148.22	20.29	1.13	1.13	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	177.81	22.09	0.93	2.97	1.30	0.37	0.93
CD14+ Monocytes, donor3	11381-118B4	140.28	17.34	2.63	1.10	1.10	1.10	2.41
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	143.79	13.87	0.28	0.57	0.00	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	139.88	10.61	0.00	0.00	0.00	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	139.39	11.51	0.00	0.33	0.00	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	203.81	27.61	2.60	4.48	1.16	1.88	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	196.13	27.16	1.21	2.72	2.41	0.60	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	230.73	26.53	1.90	3.32	1.42	0.24	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	195.86	24.44	1.67	5.52	0.67	1.34	1.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	189.90	19.60	1.38	4.14	0.55	0.83	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	274.71	29.75	2.73	2.73	1.24	1.24	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	172.30	24.67	0.39	3.33	1.57	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	158.29	20.48	1.25	2.31	1.07	0.71	0.89
CD14+ monocytes - treated with BCG, donor3	11880-125C8	366.71	26.99	0.87	5.66	0.87	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	202.05	26.22	0.47	2.81	1.64	1.17	1.17
CD14+ monocytes - treated with Candida, donor2	11878-125C6	205.40	28.51	5.81	1.58	0.53	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	284.00	26.62	3.33	2.22	1.11	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	193.22	25.44	3.72	5.06	1.34	1.34	0.89
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	218.70	30.53	2.59	2.20	1.40	0.40	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	380.17	36.64	1.25	3.33	1.04	0.62	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	215.97	31.34	1.37	6.86	1.60	1.14	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	323.47	24.88	0.68	2.49	0.68	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	225.65	24.01	1.75	3.49	0.44	1.75	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	211.16	25.82	1.08	2.69	0.54	0.54	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	177.43	25.30	1.92	4.36	1.22	0.17	1.40
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	237.34	29.88	3.79	3.37	0.42	1.26	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	229.64	34.35	3.31	6.98	2.94	2.02	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	244.47	29.94	0.70	3.17	1.41	1.06	1.76
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	271.57	35.54	1.75	3.07	0.88	1.32	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	165.48	23.19	4.88	5.58	2.09	1.92	1.39
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	205.54	25.27	3.35	3.72	1.12	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	407.82	34.92	1.94	2.80	0.65	0.22	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	194.92	21.70	1.64	4.50	0.41	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	367.86	28.97	1.39	1.16	0.93	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	390.21	26.91	0.23	2.32	0.23	0.23	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	183.09	15.26	1.31	1.74	0.22	0.44	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	175.09	22.64	0.92	2.31	0.69	0.46	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	195.60	17.76	0.65	0.87	0.43	0.00	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	169.89	23.36	0.93	0.78	0.16	0.16	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	215.51	22.01	0.52	0.87	0.52	0.17	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	362.10	31.66	1.34	1.78	0.45	0.22	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	147.49	12.25	0.77	0.77	0.51	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	184.65	20.20	0.88	2.42	0.22	0.00	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	209.70	20.00	0.84	0.63	0.42	0.00	0.84
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	247.94	8.13	2.03	0.00	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	232.55	12.88	1.36	0.68	0.68	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	310.68	10.36	0.00	1.04	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	283.58	21.32	0.00	1.60	0.53	0.53	2.67
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	339.87	15.01	0.00	1.07	0.54	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	272.35	15.44	2.11	1.40	0.00	0.70	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	305.11	10.98	2.35	0.78	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	301.89	15.82	0.00	0.00	0.00	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	238.35	17.26	2.47	0.82	2.47	0.82	4.93
CD19+ B Cells, donor2	11624-122B4	381.57	23.21	2.18	2.18	2.18	0.00	6.53
CD19+ B Cells, donor3	11705-123B4	296.84	21.20	3.03	1.51	1.51	0.00	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	813.37	83.64	3.23	1.62	1.21	2.02	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	564.08	41.55	2.40	0.80	0.80	0.00	0.80
CD34+ Progenitors, donor1	11545-120B6	110.45	11.04	0.00	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	325.85	35.39	0.00	0.56	0.00	0.00	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	252.13	30.44	1.88	0.75	0.00	0.38	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	303.05	40.36	1.13	0.45	0.45	0.45	0.23
CD4+ T Cells, donor1	11225-116C1	487.03	37.49	2.14	2.14	0.71	1.43	1.43
CD4+ T Cells, donor2	11306-117C1	364.36	38.58	4.90	8.57	6.12	4.90	8.57
CD4+ T Cells, donor3	11382-118B5	268.09	29.28	3.35	7.32	2.44	1.22	2.74
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	190.66	12.00	0.51	1.53	0.51	0.26	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	214.27	11.45	0.22	0.90	0.00	0.00	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	194.32	6.90	0.57	0.29	0.00	0.00	2.59
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	396.81	24.65	1.42	2.84	0.95	0.00	1.90
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	442.46	35.12	4.21	5.62	0.70	0.00	2.11
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	326.33	26.37	3.30	0.00	3.30	0.00	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	149.28	11.99	0.72	1.45	0.58	0.29	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	113.20	9.66	0.68	0.85	0.17	0.85	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	119.61	9.03	1.61	0.81	0.81	0.32	1.13
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	311.57	16.59	2.24	3.14	1.34	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	290.69	20.61	1.75	2.80	1.75	0.35	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	542.06	19.36	1.76	2.20	2.20	1.32	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	228.95	17.29	0.84	0.84	0.00	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	128.61	11.43	3.12	1.45	0.83	0.83	1.66
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	132.65	10.36	1.00	1.34	1.00	1.34	1.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	343.73	19.58	1.90	1.90	0.54	1.36	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	423.94	19.29	1.61	3.22	0.54	1.07	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	320.99	39.45	3.59	3.59	0.00	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	190.25	20.95	0.74	0.56	0.19	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	137.99	12.13	0.43	0.87	0.22	0.22	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	128.19	9.88	0.42	0.42	0.00	0.00	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	266.45	25.28	2.53	2.02	0.51	0.51	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	290.71	27.73	1.30	1.73	0.87	0.43	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	506.85	30.51	1.31	3.05	0.87	0.44	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	338.00	21.28	0.99	1.48	0.49	0.00	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	351.73	9.23	1.85	0.92	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	332.21	12.56	2.79	4.19	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	398.22	30.46	2.77	0.55	0.28	0.28	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	539.12	25.03	3.19	1.47	0.00	0.25	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	471.24	7.70	1.54	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	412.91	17.55	0.36	1.43	0.72	0.36	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	385.03	30.47	2.77	1.38	0.00	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	400.73	37.32	1.31	1.96	1.64	1.31	2.29
CD8+ T Cells, donor2	11307-117C2	301.10	26.28	6.38	10.51	4.88	1.50	4.13
CD8+ T Cells, donor3	11383-118B6	337.07	33.58	2.78	5.55	2.78	1.01	5.55
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	160.12	18.35	2.06	1.38	0.46	1.15	1.15
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	149.06	22.29	0.72	1.44	0.24	0.72	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	149.93	16.69	0.55	1.09	0.55	2.19	1.37
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	187.03	31.52	0.60	0.90	0.30	0.60	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	133.67	13.20	1.68	0.48	0.24	0.96	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	156.67	18.65	0.45	0.23	0.68	0.00	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	138.63	14.56	0.43	0.00	1.09	0.65	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	144.24	14.48	1.32	0.53	0.53	0.53	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	130.63	15.24	0.70	0.47	0.00	0.70	1.17
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	165.13	21.43	0.60	1.21	1.21	1.81	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	153.68	17.72	0.58	0.29	0.00	1.45	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	157.46	21.05	0.80	0.27	0.27	0.00	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	170.29	14.88	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	177.62	24.59	0.46	0.46	0.46	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	140.22	9.70	0.00	0.75	0.00	0.00	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	135.06	18.73	0.72	0.36	0.36	0.00	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	133.50	18.99	0.29	0.29	0.29	0.00	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	108.42	12.02	0.94	0.24	0.47	0.94	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	195.53	19.65	0.63	0.95	0.00	0.32	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	168.85	17.53	1.23	0.00	2.15	0.00	1.85
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	150.67	15.07	0.00	0.32	0.32	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	199.65	23.33	0.76	0.38	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	173.80	20.10	1.97	0.00	0.39	0.39	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	184.56	10.59	0.00	0.76	1.51	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	349.29	28.10	0.80	0.00	1.61	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	321.74	36.37	1.40	0.00	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	421.74	41.07	2.00	2.00	0.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	82.25	16.45	1.83	1.83	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	102.77	8.89	1.98	1.98	0.49	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	136.07	19.57	0.53	0.32	0.32	0.11	0.00
Chondrocyte - de diff, donor1	11261-116G1	170.91	23.23	1.39	1.39	0.35	0.35	1.04
Chondrocyte - de diff, donor2	11338-117F6	45.84	6.04	0.00	0.00	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	73.73	12.06	1.14	1.25	0.57	0.34	0.91
Chondrocyte - re diff, donor2	11339-117F7	269.47	24.17	0.00	0.90	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	70.37	8.49	0.81	0.40	0.00	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	250.52	25.36	1.38	0.80	0.34	0.69	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	125.05	12.40	2.99	2.57	0.86	1.28	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	143.28	16.81	3.27	1.24	0.71	0.88	1.15
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	154.33	15.59	1.47	0.64	0.28	0.83	0.09
Corneal Epithelial Cells, donor1	11526-119I5	40.40	2.85	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	35.27	3.41	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	44.99	8.18	1.02	0.51	0.00	0.26	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	66.37	7.76	0.00	0.00	0.33	0.17	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	63.08	7.57	0.32	0.32	0.00	0.00	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	75.92	3.45	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	47.41	7.45	0.65	0.54	0.22	0.32	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	223.09	29.38	0.34	0.34	1.37	0.00	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	239.60	26.11	0.00	0.00	0.00	0.00	2.61
Dendritic Cells - plasmacytoid, donor3	11385-118B8	251.17	27.10	0.48	0.97	0.48	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	55.20	10.51	0.00	0.00	0.17	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	48.12	9.98	0.00	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	83.43	11.59	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	38.14	2.75	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	68.94	9.89	0.87	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	109.40	21.88	2.82	1.41	2.12	1.41	0.00
Endothelial Cells - Artery, donor3	11413-118E9	64.51	14.20	0.53	0.53	0.18	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	73.37	8.64	0.44	0.89	0.00	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	88.54	14.60	0.30	0.61	0.30	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	116.43	15.50	0.28	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	74.28	14.86	0.30	0.59	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	46.86	4.17	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	28.50	5.96	0.71	0.28	0.00	0.85	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	227.27	36.81	1.60	0.40	0.80	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	41.41	8.91	1.05	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	304.65	46.22	1.99	1.49	0.25	1.74	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	148.39	29.98	2.39	0.22	0.65	0.43	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	202.85	38.47	1.22	0.98	0.37	0.12	0.12
Endothelial Cells - Vein, donor1	11267-116G7	58.01	9.10	1.14	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	43.31	2.10	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	53.23	11.30	0.31	0.47	0.00	0.00	0.47
Eosinophils, donor1	12244-129H3	396.42	15.25	0.00	0.00	0.00	15.25	0.00
Eosinophils, donor2	12245-129H4	1401.07	64.36	0.00	6.60	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	859.60	42.80	0.00	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	27.85	3.42	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	14.56	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	16.27	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	89.49	15.60	2.05	0.82	0.82	1.23	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	22.34	2.96	0.00	0.33	0.22	0.11	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	80.39	8.23	0.43	0.33	0.43	0.22	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	159.24	21.59	1.46	0.73	0.24	1.09	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	95.80	15.83	0.82	0.27	0.00	0.00	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	56.53	5.17	0.95	0.84	0.32	0.32	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	169.42	21.08	3.43	2.11	0.26	1.84	3.69
Fibroblast - Aortic Adventitial, donor3	11401-118D6	139.19	19.93	3.32	2.66	1.00	2.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	67.14	9.07	0.91	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	48.51	7.58	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	47.31	10.25	1.42	0.16	0.63	0.32	0.00
Fibroblast - Cardiac, donor4	11452-119A3	176.41	21.82	0.00	0.00	0.30	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	97.08	17.51	2.54	0.89	0.25	0.51	0.25
Fibroblast - Cardiac, donor6	11460-119B2	133.25	24.56	1.06	0.15	0.45	0.76	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	69.94	9.51	0.00	0.27	0.13	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	54.79	6.47	0.86	0.00	0.43	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	188.96	23.44	10.25	11.72	5.86	4.39	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	151.76	17.99	0.23	0.92	0.69	0.46	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	121.27	9.67	1.36	0.17	0.17	0.51	0.17
Fibroblast - Dermal, donor1	11269-116G9	64.33	6.34	0.47	0.23	0.00	0.00	0.70
Fibroblast - Dermal, donor2	11346-117G5	100.47	8.02	0.47	0.47	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	66.61	9.55	2.06	0.48	0.24	0.48	0.24
Fibroblast - Dermal, donor4	11450-119A1	185.28	31.54	3.28	1.81	1.02	0.57	0.23
Fibroblast - Dermal, donor5	11454-119A5	237.95	36.11	2.79	1.74	0.52	1.40	0.00
Fibroblast - Dermal, donor6	11458-119A9	282.13	43.20	4.71	1.30	1.30	1.30	0.00
Fibroblast - Gingival, donor1	11237-116D4	164.29	21.86	0.62	0.42	0.21	0.00	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	164.80	21.75	1.57	0.26	0.79	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	230.09	24.91	6.33	2.64	1.19	3.16	0.26
Fibroblast - Gingival, donor3	11394-118C8	132.27	17.40	0.68	0.48	0.39	0.19	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	105.97	11.43	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	64.84	7.05	1.76	1.41	0.70	0.70	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	218.10	24.16	0.78	0.94	1.09	1.25	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	175.66	19.47	0.54	0.95	1.08	0.14	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	91.75	8.82	0.35	0.00	0.00	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	157.65	18.43	0.73	0.29	0.15	0.44	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	219.53	21.27	0.95	0.68	0.82	0.82	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	344.33	38.94	2.08	0.44	0.44	0.66	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	90.54	9.39	0.44	0.29	0.00	0.44	0.15
Fibroblast - Lung, donor1	11270-116H1	21.75	1.36	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	256.65	20.89	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	120.71	17.73	2.32	1.48	0.00	1.06	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	79.14	14.99	0.00	0.83	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	29.37	1.40	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	6.44	1.96	0.56	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	138.03	19.49	0.00	0.41	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	55.92	7.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	47.65	17.87	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	309.97	37.82	1.55	1.75	0.00	0.97	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	309.58	44.44	5.76	4.10	1.97	1.67	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	311.50	47.73	0.92	0.61	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	177.45	18.70	1.53	0.38	0.38	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	86.94	12.69	1.89	1.35	0.54	1.08	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	78.05	8.93	1.28	0.81	0.23	0.23	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	194.98	27.30	1.44	0.66	0.22	0.55	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	117.65	12.39	0.20	0.20	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	67.49	8.02	0.00	1.34	0.67	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	98.44	11.86	1.58	0.40	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	272.07	34.73	3.18	1.79	0.40	2.18	3.18
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	134.46	7.64	0.53	0.18	0.36	0.36	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	170.08	14.39	0.79	0.79	0.20	0.39	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	213.01	25.27	1.50	0.90	1.20	0.90	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	221.52	23.53	1.84	1.08	0.65	0.22	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	144.76	18.73	1.52	0.00	0.51	1.27	2.28
Fibroblast - skin normal, donor1	11553-120C5	122.89	8.53	0.49	0.49	0.49	0.33	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	243.82	34.09	1.40	0.60	0.20	1.00	1.20
Fibroblast - skin normal, donor2	11561-120D4	232.37	27.63	2.21	1.31	0.20	0.90	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	221.84	31.13	2.72	1.21	0.30	0.30	3.02
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	129.99	8.78	0.25	0.83	0.08	0.08	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	112.14	9.06	0.85	1.37	0.17	0.34	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	204.94	25.95	1.31	1.97	0.66	0.33	1.64
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	242.98	32.70	1.49	1.28	0.43	0.96	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	237.67	20.41	2.19	0.84	0.34	0.84	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	120.91	13.64	1.10	1.10	0.78	0.16	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	5539.95	1063.67	88.64	88.64	22.16	44.32	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	131.60	18.30	0.87	1.74	2.61	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	76.45	11.79	0.17	0.00	0.17	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	140.79	16.13	0.78	0.00	0.26	0.52	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	114.47	15.59	0.51	0.00	0.00	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	203.64	16.84	0.77	2.30	0.00	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	323.50	22.97	2.55	1.91	0.00	0.64	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	559.69	63.04	7.70	7.70	3.14	4.56	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	496.91	29.23	11.03	6.34	3.86	3.86	2.48
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	281.98	24.89	5.71	5.94	1.60	3.42	2.05
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	384.17	40.22	4.95	4.16	3.96	5.15	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	425.32	34.36	7.67	3.97	3.70	4.76	3.44
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	241.02	27.72	3.91	2.94	0.65	0.33	2.61
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	444.43	44.22	12.38	9.73	6.63	8.40	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	348.36	45.65	5.09	2.97	1.41	2.26	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	286.31	31.77	7.27	3.08	2.09	2.22	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	309.46	35.73	4.84	4.03	1.07	3.49	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	257.33	32.46	4.96	2.48	1.24	2.60	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	274.91	35.16	6.09	1.25	1.66	3.32	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	264.29	22.57	5.49	2.24	2.85	1.83	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	221.56	23.27	2.51	1.14	0.68	0.68	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	205.78	22.67	5.36	1.25	1.87	1.87	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	189.94	21.20	1.53	2.19	0.87	1.31	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	227.22	18.91	4.43	0.89	0.30	1.77	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	257.19	31.79	7.95	3.18	2.23	2.54	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	211.58	21.45	2.01	1.56	1.56	1.12	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	268.17	26.82	5.24	3.63	2.02	3.43	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	277.36	35.96	6.28	3.39	0.85	3.22	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	379.43	34.05	0.98	1.68	0.89	0.98	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	334.12	34.03	0.83	1.04	0.21	0.73	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	431.21	31.42	0.85	0.51	0.51	1.02	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	239.57	37.84	4.54	2.55	1.44	1.33	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	323.80	32.11	0.67	1.16	0.50	0.67	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	445.73	33.89	1.23	0.82	0.82	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	257.06	27.85	2.48	2.27	2.06	1.86	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	236.47	31.59	6.34	2.42	1.38	2.31	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	210.29	24.01	3.84	2.33	2.00	0.83	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	192.22	19.62	1.76	1.54	1.10	2.20	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	244.02	27.67	5.66	1.72	1.72	2.46	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	231.31	25.61	3.40	1.46	0.65	2.59	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	254.65	15.07	2.25	0.96	0.96	2.57	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	162.12	22.93	5.02	1.52	1.04	2.37	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	159.44	21.35	3.01	0.63	1.11	1.11	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	193.70	20.07	3.04	2.43	1.22	2.13	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	172.28	25.19	3.55	3.24	1.05	2.51	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	155.23	19.98	1.98	1.32	1.10	1.76	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	205.08	17.96	3.09	1.12	1.12	1.68	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	123.51	21.67	1.67	1.11	0.74	1.02	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	174.08	14.71	2.94	2.41	0.00	1.34	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	173.66	20.04	2.14	1.68	0.15	1.38	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	123.97	19.17	2.59	1.42	0.39	0.52	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	136.35	16.81	1.08	0.27	0.81	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	162.41	20.09	2.95	1.47	1.11	2.77	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	153.96	14.26	3.29	0.88	1.10	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	231.08	35.70	2.98	0.00	1.98	1.98	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	140.09	17.02	2.37	0.66	0.79	1.19	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	124.69	13.92	2.02	1.01	1.21	0.81	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	334.98	37.62	1.27	0.25	0.51	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	649.53	73.06	4.78	2.79	1.59	2.59	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	384.73	54.39	8.01	2.00	2.77	3.85	0.92
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	530.89	67.72	6.14	2.05	1.84	2.66	1.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	325.13	29.10	0.63	0.63	0.94	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	289.34	29.67	0.85	0.85	0.28	0.57	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	286.41	23.98	3.23	1.84	2.77	2.77	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	378.64	27.22	9.90	4.95	0.00	0.00	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	453.73	36.36	8.12	5.03	1.55	3.09	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	295.22	24.07	3.21	4.81	0.00	0.00	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	384.28	34.78	12.17	3.48	3.48	5.22	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	391.23	36.45	4.56	2.60	0.65	2.28	1.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	483.04	43.65	8.24	2.88	4.12	3.29	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	396.54	39.99	19.99	13.33	26.66	13.33	13.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	365.50	29.64	4.19	2.80	2.80	1.40	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	403.98	37.26	3.60	3.27	3.27	1.96	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	389.22	29.36	14.26	7.55	6.71	10.07	6.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	404.27	34.03	5.73	1.59	1.27	2.86	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	423.56	36.00	6.11	2.04	2.38	2.04	2.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	306.96	22.97	8.35	2.09	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	448.42	39.52	6.30	3.44	0.57	2.86	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	290.95	25.45	5.92	2.37	2.37	2.07	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	301.56	32.19	20.33	11.86	6.78	6.78	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	409.65	42.66	6.63	3.73	1.24	4.56	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	427.81	42.11	3.22	1.15	1.38	2.07	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	284.50	21.07	0.00	5.27	15.81	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	287.54	33.83	6.15	5.00	1.54	1.92	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	301.52	29.34	4.56	1.63	0.98	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	228.74	22.74	0.67	2.68	1.34	1.34	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	366.78	31.98	5.39	1.93	1.16	4.24	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	372.47	38.00	4.79	3.77	1.37	2.40	3.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	439.81	27.33	9.94	4.97	7.45	9.94	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	426.08	29.73	3.30	1.42	1.89	0.94	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	337.35	26.55	4.22	6.03	0.60	3.62	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	335.22	28.99	2.54	1.53	1.02	2.54	2.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	350.18	33.90	5.18	0.80	2.39	1.99	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	403.56	34.04	2.47	2.47	1.97	2.96	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	416.70	34.23	9.44	9.44	4.72	4.72	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	322.65	18.09	3.50	1.75	2.92	2.33	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	366.47	25.02	4.39	2.19	1.32	1.32	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	277.20	26.28	10.17	3.39	2.54	3.39	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	199.37	28.05	6.57	4.18	2.39	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	217.39	32.51	6.31	2.91	1.94	1.94	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	49.08	0.00	1.14	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	58.21	7.07	3.33	0.83	0.42	2.08	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	35.98	2.25	1.12	0.00	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	52.97	5.07	1.59	0.63	0.32	0.63	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	24.65	2.51	0.00	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	158.28	27.50	3.60	2.44	1.28	1.28	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	195.81	30.38	4.56	1.35	1.35	0.84	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	201.80	31.17	2.73	2.73	1.59	0.91	0.91
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	162.87	27.87	4.37	3.50	1.53	2.40	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	181.82	30.52	2.15	2.58	1.29	0.64	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	205.81	26.48	3.88	1.51	1.29	1.72	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	98.01	16.07	2.12	1.37	0.87	0.87	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	128.83	14.92	2.23	1.20	0.34	0.86	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	127.19	19.54	2.88	1.60	0.32	0.96	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	31.90	5.04	0.00	0.00	0.56	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	23.80	7.36	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	140.12	13.22	2.64	7.93	0.00	7.93	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	38.45	3.17	0.35	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	35.60	0.73	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	148.96	18.01	4.55	1.57	1.40	1.75	0.00
Hepatocyte, donor1	11523-119I2	69.00	9.68	1.21	0.00	2.42	0.00	0.00
Hepatocyte, donor2	11603-120I1	127.13	14.01	0.00	2.15	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	85.90	12.27	3.68	1.23	0.00	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	286.53	38.51	4.57	3.92	3.92	1.96	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	341.17	35.48	2.45	2.27	0.87	1.05	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	154.22	16.88	1.51	0.82	0.27	0.27	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	181.48	28.66	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	113.48	6.68	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	243.75	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	112.13	26.30	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	87.59	10.01	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	118.68	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	148.65	23.07	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	118.84	13.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	126.70	27.61	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	175.07	30.01	1.67	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	130.70	3.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	156.17	31.76	0.00	2.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	227.27	25.50	1.11	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	361.44	26.19	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	237.46	38.42	0.00	0.00	0.00	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	301.59	55.68	0.00	1.55	1.55	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	526.85	43.90	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	287.49	48.45	1.29	0.65	1.29	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	399.26	53.13	0.00	1.61	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	597.41	59.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	314.54	55.41	0.00	0.00	1.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	160.79	20.99	0.84	0.42	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	244.33	28.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	292.54	52.24	0.80	0.00	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	183.73	26.78	0.92	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	482.58	60.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	105.74	23.60	0.00	0.94	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	184.12	27.21	0.00	0.91	0.91	0.91	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	486.50	73.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	235.67	41.97	0.00	0.00	1.08	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	294.75	35.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	377.90	32.86	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	249.97	40.81	0.64	0.00	0.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	226.01	29.16	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	663.78	31.61	0.00	0.00	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	197.80	43.56	0.00	0.71	0.00	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	358.38	43.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	458.67	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	131.80	22.53	0.31	0.31	0.31	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	282.72	38.63	0.00	0.00	0.00	1.76	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	396.03	28.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	168.28	25.03	0.00	0.00	0.00	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	86.31	13.28	0.00	0.00	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	129.68	32.42	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	72.37	9.59	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	96.74	13.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	111.51	10.45	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	70.41	12.80	0.00	0.00	0.00	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	117.76	22.17	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	296.36	45.59	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	94.80	16.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	87.73	6.05	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	186.26	6.21	0.00	0.00	0.00	0.00	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	52.87	6.34	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	102.65	10.12	0.41	0.82	0.41	0.49	0.00
Keratinocyte - epidermal, donor2	11349-117G8	26.94	4.69	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	145.49	26.31	4.26	3.31	0.76	1.33	0.66
Keratinocyte - oral, donor1	11251-116E9	258.37	25.31	2.50	1.25	0.79	0.91	0.23
Keratocytes, donor1	11527-119I6	212.49	25.79	1.03	0.69	0.34	0.00	0.34
Keratocytes, donor2	11607-120I5	56.25	7.03	0.00	0.00	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	201.55	21.14	2.57	1.38	1.19	1.38	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	162.65	8.79	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	132.69	10.79	2.16	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	201.14	23.07	0.69	0.69	0.12	0.23	0.00
Lens Epithelial Cells, donor3	11690-122I7	108.88	16.45	0.50	0.00	0.00	0.30	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	62.13	10.08	0.47	0.36	0.24	0.12	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	32.65	4.47	0.00	0.56	0.56	0.56	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	67.21	13.69	2.99	0.94	1.57	0.79	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	60.22	5.91	0.00	0.54	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	29.00	4.73	2.21	0.63	0.00	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	30.19	5.50	1.29	0.43	0.22	0.65	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	62.79	5.34	0.82	0.00	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	15.93	2.53	0.25	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	35.19	4.79	0.42	0.70	0.56	0.28	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	50.63	6.33	0.00	0.00	0.00	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	39.75	6.01	0.19	0.58	0.58	0.19	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	13.70	2.41	1.11	0.19	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	41.46	6.97	1.74	0.70	0.35	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	34.82	5.25	0.24	0.48	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	25.00	3.71	0.96	0.41	0.14	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	51.43	3.70	0.62	0.92	0.00	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	18.08	1.87	0.31	0.00	0.62	0.31	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	31.47	4.94	0.73	0.18	0.55	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	50.68	5.27	2.30	0.99	0.66	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	20.50	3.81	0.29	0.29	0.29	0.29	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	19.17	2.24	0.50	0.25	0.25	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	57.71	12.61	0.48	0.48	0.48	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	36.62	6.19	0.00	0.00	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	33.76	5.60	0.45	0.30	0.30	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	39.40	3.63	0.52	0.52	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	46.07	10.68	1.05	0.63	0.63	1.26	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	24.06	4.51	0.00	0.15	0.30	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	35.77	10.32	0.69	0.69	0.00	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	31.23	4.70	0.19	0.19	0.19	0.38	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	20.15	3.71	0.64	0.32	0.11	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	49.43	11.15	2.91	0.97	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	31.09	3.64	0.99	0.00	0.33	0.33	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	23.17	3.22	0.12	0.37	0.99	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	61.08	11.11	1.48	0.00	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	35.09	5.44	0.49	0.74	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	18.29	2.75	0.27	0.27	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	59.18	8.36	0.96	0.64	0.00	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	45.35	5.17	0.91	0.61	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	43.81	6.44	0.42	0.56	0.56	0.42	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	54.76	5.69	1.42	0.36	0.00	0.00	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	17.94	1.45	0.48	0.00	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	16.49	2.80	0.31	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	41.18	8.95	0.72	1.43	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	30.71	5.23	0.00	0.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	13.65	1.65	0.24	0.47	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	61.38	7.55	0.12	0.37	0.12	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	15.88	2.31	0.00	0.00	0.26	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	32.82	4.77	0.00	0.00	0.00	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	74.78	4.53	0.00	0.00	0.00	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	67.51	9.21	0.77	1.53	0.77	0.77	3.07
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	72.74	8.16	0.74	0.74	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	69.82	4.65	0.42	0.42	0.00	0.42	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	45.01	9.85	1.41	2.11	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	72.85	2.80	0.00	0.93	0.93	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	65.44	5.15	2.06	1.03	0.52	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	73.75	7.14	0.00	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	61.07	7.24	0.45	0.00	0.23	0.23	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	137.85	11.63	2.33	2.62	1.74	0.29	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	145.41	17.56	0.90	0.45	1.35	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	86.03	7.86	0.14	0.14	0.27	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	83.70	8.22	1.03	1.03	0.00	0.51	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	117.85	13.06	1.41	1.06	0.71	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	135.93	13.33	0.67	1.33	0.67	2.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	84.56	6.62	1.53	2.55	0.51	0.51	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	124.33	13.87	0.53	2.40	0.27	2.13	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	140.76	16.44	3.02	1.70	0.76	0.19	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	60.74	7.98	1.23	0.00	1.23	0.61	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	80.73	15.49	0.82	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	134.32	15.62	2.08	2.08	0.83	1.04	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	135.37	13.73	4.20	1.96	1.12	2.24	1.96
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	79.34	10.30	2.06	1.03	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	125.70	14.22	4.64	3.77	1.45	1.45	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	127.64	12.85	2.39	1.49	0.30	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	136.65	7.19	0.55	1.11	1.66	1.11	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	94.03	6.72	1.77	1.06	1.06	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	96.99	7.01	1.48	1.11	1.11	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	70.23	5.76	1.15	0.00	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	85.58	9.21	2.69	1.15	1.15	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	68.50	5.66	0.57	1.13	0.00	1.13	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	81.23	10.67	0.00	1.64	0.00	0.82	2.46
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	74.11	6.78	1.36	0.00	0.00	1.36	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	73.97	7.18	2.15	0.72	0.00	0.72	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	101.58	10.46	0.75	1.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	82.87	5.57	3.72	1.86	0.37	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	115.01	5.60	0.86	0.00	0.00	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	82.20	9.42	2.57	0.00	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	86.96	10.33	1.67	0.67	0.00	1.67	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	79.64	10.86	1.21	0.60	0.00	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	48.35	4.98	0.00	0.00	0.71	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	70.46	5.16	2.06	0.69	1.03	0.00	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	77.83	8.59	0.54	0.54	0.54	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	53.87	8.08	0.67	2.02	0.00	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	72.23	13.33	0.74	0.74	0.00	0.37	1.48
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	100.01	8.14	1.16	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	58.18	6.35	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	62.42	10.00	0.80	2.00	1.20	0.40	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	63.24	5.81	0.00	0.73	0.00	1.45	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	52.89	9.20	0.00	0.00	0.00	0.00	3.07
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	68.07	5.43	1.97	0.49	0.00	0.99	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	81.86	3.76	0.00	0.94	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	47.27	9.55	1.01	0.00	0.00	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	68.49	8.56	1.35	0.45	0.00	0.00	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	89.50	6.88	0.00	0.00	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	68.58	7.57	0.00	0.00	0.00	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	80.55	5.87	0.39	0.78	0.78	0.39	3.13
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	75.21	5.94	1.98	0.00	0.66	0.66	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	66.42	11.42	0.00	0.52	0.00	0.52	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	82.26	10.94	2.19	2.63	0.44	1.31	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	101.20	5.03	1.68	0.56	0.00	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	66.25	9.72	0.44	0.00	0.00	0.00	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	86.01	13.50	1.54	0.00	0.39	0.39	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	84.05	6.58	0.51	1.01	0.00	0.51	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	91.80	10.57	0.96	2.40	0.00	0.00	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	79.51	6.76	0.80	0.80	0.40	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	100.26	6.08	0.61	1.22	1.22	1.22	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	73.32	4.15	0.69	0.69	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	95.76	8.36	1.14	1.52	0.00	1.14	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	99.15	8.78	1.03	1.03	1.03	0.00	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	70.14	6.05	0.00	0.00	0.00	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	80.49	9.19	1.58	1.90	0.63	0.32	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	84.23	4.80	0.53	1.07	0.00	0.00	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	51.72	4.02	1.15	0.00	0.00	0.00	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	91.02	11.31	0.51	1.54	0.51	1.03	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	89.83	9.20	0.71	0.00	0.00	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	78.88	10.21	0.00	1.13	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	73.64	7.07	1.66	0.83	0.83	0.83	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	97.10	7.05	0.00	0.78	0.00	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	59.29	9.60	0.00	0.42	0.84	1.67	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	66.44	8.36	2.32	1.39	0.00	0.46	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	90.32	8.03	0.67	0.00	0.67	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	80.20	9.09	2.67	1.07	0.00	1.07	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	76.37	8.08	2.02	0.81	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	50.48	4.59	0.00	0.00	0.00	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	61.35	8.00	1.78	0.89	1.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	72.37	2.28	0.57	0.57	0.00	1.14	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	58.28	6.90	0.00	0.00	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	111.62	11.49	0.55	1.64	1.64	1.09	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	66.37	9.80	0.45	0.45	0.45	0.45	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	68.37	5.20	0.00	0.00	0.00	0.26	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	84.88	2.65	0.00	1.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	93.54	4.16	6.24	0.00	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	95.27	11.40	0.91	0.46	0.23	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	62.94	7.16	0.37	0.37	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	73.67	9.04	1.44	0.39	0.26	0.39	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	89.74	9.03	1.06	0.53	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	217.24	20.12	0.00	0.48	0.48	0.32	0.00
Mallassez-derived cells, donor3	11930-125I4	229.47	22.10	0.83	0.28	0.14	0.14	0.14
Mammary Epithelial Cell, donor1	11273-116H4	211.84	31.79	1.20	1.10	0.60	0.70	0.00
Mammary Epithelial Cell, donor2	11350-117G9	230.77	20.27	1.45	0.87	0.58	0.58	0.00
Mammary Epithelial Cell, donor3	11422-118F9	29.43	4.24	1.25	0.00	0.75	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	1454.85	194.57	0.68	2.03	0.00	4.07	2.03
Mast cell, donor1	11563-120D6	212.71	25.30	0.65	0.54	0.32	0.43	0.32
Mast cell, donor2	11565-120D8	328.08	25.85	1.19	0.59	0.00	0.30	0.00
Mast cell, donor3	11566-120D9	453.85	37.15	2.25	1.58	1.13	0.23	0.23
Mast cell, donor4	11567-120E1	318.41	29.96	0.71	0.71	0.35	0.71	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	334.45	38.26	1.55	2.22	1.11	1.33	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	265.58	17.51	0.58	0.00	0.00	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	230.36	21.34	0.69	0.92	0.23	0.46	0.34
Mast cell, expanded, donor8	11941-126A6	164.02	13.56	0.17	0.33	0.33	0.84	0.33
Melanocyte - dark, donor1	11502-119F8	131.93	23.88	0.60	0.40	0.30	0.10	0.00
Melanocyte - dark, donor2	11582-120F7	108.67	12.46	2.77	1.04	0.35	2.08	0.00
Melanocyte - dark, donor3	11663-122F7	187.11	23.47	0.72	0.22	0.43	0.58	0.14
Melanocyte - light, donor1	11274-116H5	49.37	6.35	0.24	0.24	0.24	0.00	0.24
Melanocyte - light, donor2	11351-117H1	29.35	4.78	0.68	0.00	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	11.27	1.73	0.00	0.00	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	123.49	17.18	2.60	1.04	0.52	0.83	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	96.01	13.98	2.15	0.27	0.81	0.27	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	166.34	23.30	3.21	0.80	0.80	0.27	0.27
Meningeal Cells, donor1	11493-119E8	172.44	20.97	0.62	0.00	0.50	0.12	0.12
Meningeal Cells, donor2	11573-120E7	98.59	18.05	0.88	0.44	0.00	0.44	0.44
Meningeal Cells, donor3	11654-122E7	359.10	31.87	1.39	1.47	0.82	1.55	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	202.46	23.67	0.86	1.14	0.86	1.14	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	68.73	7.14	0.40	0.10	0.20	0.00	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	17.08	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	30.09	1.31	2.62	0.00	0.00	1.31	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	139.22	14.35	4.31	0.72	0.00	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	118.38	8.47	0.64	0.64	0.21	0.42	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	122.14	15.08	1.01	1.51	2.01	0.50	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	103.28	9.23	0.66	0.22	0.00	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	72.33	8.04	1.46	0.73	0.73	1.46	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	45.22	7.98	0.61	0.20	0.20	0.41	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	106.65	6.93	0.55	0.28	0.14	0.00	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	24.16	2.60	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	154.73	13.55	1.32	0.66	1.18	0.53	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	35.31	4.45	0.59	0.30	0.30	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	37.37	2.34	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	51.23	7.04	1.28	0.64	1.28	1.92	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	200.26	27.65	1.06	0.00	0.71	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	115.71	17.83	0.94	0.00	0.00	0.63	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	165.46	12.34	2.18	0.73	0.73	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	63.11	9.55	0.53	0.53	0.27	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	46.54	7.51	0.50	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	46.76	9.18	1.37	0.72	0.51	0.65	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	59.41	10.80	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	65.76	8.62	1.72	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	42.11	7.07	0.00	0.29	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	24.20	6.91	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	47.73	2.79	0.00	0.62	0.62	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	39.00	5.81	0.83	0.62	0.41	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	30.11	4.63	2.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	49.55	6.76	0.50	0.25	0.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	54.93	6.98	0.00	0.47	0.00	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	44.71	6.50	1.02	0.61	0.20	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	34.05	3.56	0.00	0.79	0.79	0.40	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	40.71	2.65	0.00	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	46.73	6.84	1.52	0.00	0.38	0.00	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	17.11	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	47.96	4.46	0.64	0.64	0.21	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	23.02	3.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	38.45	7.45	0.00	0.60	0.30	0.30	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	16.77	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	33.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	56.20	5.27	0.00	0.25	0.25	0.25	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	39.45	6.42	0.95	0.71	0.24	0.24	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	31.51	4.42	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	69.07	9.67	0.92	0.92	0.00	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	35.76	5.47	0.84	0.00	0.21	0.42	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	50.96	7.13	0.20	0.00	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	60.50	7.08	0.43	0.21	0.86	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	43.79	5.33	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	55.19	5.26	0.44	0.00	0.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	37.51	3.55	0.00	0.00	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	28.17	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	64.41	6.52	0.27	0.54	0.54	0.82	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	43.23	5.59	0.59	0.00	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	19.63	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	38.92	5.77	0.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	36.42	5.20	0.00	0.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	32.91	1.37	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	38.54	4.51	0.00	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	40.77	2.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	57.37	7.01	0.00	0.44	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	24.28	1.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	23.05	3.20	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	66.94	7.93	0.25	0.50	0.50	0.00	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	31.32	2.78	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	44.20	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	57.78	3.08	0.34	1.71	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	31.95	6.13	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	37.29	5.33	0.71	0.00	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	61.44	7.01	0.56	0.28	0.28	0.00	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	36.58	1.66	0.83	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	27.39	4.08	0.00	0.00	1.17	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	45.85	3.92	0.90	0.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	48.83	7.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	54.49	2.77	0.00	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	70.57	3.41	0.57	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	51.82	6.77	0.14	0.14	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	62.97	3.89	0.52	0.26	0.26	0.52	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	66.92	9.87	0.86	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	38.11	1.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	61.12	6.14	0.27	0.80	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	79.62	7.48	0.60	0.30	0.30	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	44.21	6.50	0.42	0.00	0.42	0.28	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	66.57	6.05	0.00	0.64	0.00	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	77.84	7.30	0.44	0.66	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	45.12	7.20	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	76.99	6.82	0.57	0.28	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	71.28	9.83	0.25	0.25	0.00	0.49	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	32.58	7.17	0.00	0.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	73.80	5.59	0.00	0.59	1.18	0.88	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	64.59	6.34	0.58	0.29	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	107.57	8.66	0.41	0.00	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	63.13	6.25	0.30	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	60.27	0.00	3.77	0.00	0.00	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	60.60	3.56	1.78	0.00	0.00	0.00	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	89.37	8.87	1.31	0.99	0.00	1.64	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	55.75	3.16	0.00	2.10	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	75.71	6.33	0.20	0.59	0.20	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	81.02	7.45	0.93	0.00	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	80.74	7.14	1.13	0.38	1.50	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	43.41	4.53	0.27	0.00	0.53	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	97.38	7.69	0.34	0.11	0.23	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	52.31	3.68	0.00	1.47	0.00	3.68	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	67.42	6.96	0.00	0.00	0.00	1.83	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	90.22	4.67	1.56	1.56	3.11	1.56	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	175.83	8.02	0.53	0.53	0.53	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	27.05	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	44.44	4.04	0.00	0.00	2.02	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	88.12	6.32	0.84	0.84	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	241.06	21.79	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	193.92	19.71	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	289.92	12.96	0.81	0.81	0.00	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	80.05	7.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	639.54	68.52	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	554.62	35.89	0.00	0.00	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	256.63	47.52	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	200.78	12.55	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	149.94	13.36	1.51	0.65	0.00	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	114.45	17.25	1.57	1.05	0.00	1.05	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	76.76	6.01	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	25.04	2.50	0.42	0.42	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	184.63	25.29	0.38	1.33	0.76	0.57	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	333.53	31.92	0.00	1.60	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	34.68	2.04	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	746.08	108.42	5.51	3.68	1.84	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	29.30	0.00	0.42	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	51.83	7.67	0.00	0.23	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	54.05	5.13	0.00	0.27	0.00	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	124.04	15.98	1.05	0.00	0.42	0.63	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	2393.97	200.42	11.13	0.00	22.27	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	47.65	7.45	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	56.30	4.60	0.00	0.00	0.00	0.00	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	37.86	2.49	0.00	0.00	0.45	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	29.39	2.78	0.00	0.16	0.16	0.33	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	104.25	11.66	1.28	0.36	0.18	0.36	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	37.66	3.71	0.00	0.00	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	19.81	3.00	0.00	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	145.71	9.19	0.98	0.33	0.00	0.98	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	20.82	1.95	0.00	0.00	0.00	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	126.64	12.17	0.71	0.18	0.88	0.00	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	21.80	2.11	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	23.90	0.92	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	42.10	2.57	0.00	0.00	0.32	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	95.88	13.11	0.69	0.69	0.69	0.34	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	735.78	111.25	7.59	2.53	2.53	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	93.79	9.80	0.22	0.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	27.52	1.27	0.00	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	39.88	4.51	0.24	0.24	0.00	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	48.93	4.29	0.00	0.00	0.00	0.00	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	1742.36	207.64	0.00	0.00	0.00	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	37.32	5.33	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	96.48	9.47	0.00	0.90	0.00	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	47.62	3.57	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	47.36	2.79	0.00	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	61.30	3.78	0.76	0.00	0.38	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	38.45	3.26	0.00	0.00	0.00	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	22.23	1.31	0.00	0.00	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	149.71	9.95	0.90	0.00	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	52.03	4.41	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	53.19	2.66	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	62.50	6.45	0.00	0.00	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	39.43	5.36	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	70.47	6.96	0.30	0.30	0.60	0.30	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	129.08	9.95	1.55	0.66	0.44	0.22	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	29.82	7.45	0.00	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	1001.47	117.52	5.11	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	38.41	3.66	0.00	0.00	0.61	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	25.49	2.83	0.00	0.63	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	36.32	3.63	0.30	0.30	0.30	0.00	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	41.93	6.33	0.00	0.00	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	189.32	13.60	1.13	0.00	0.00	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	1203.78	75.87	30.35	10.12	0.00	15.17	0.00
Myoblast, donor1	11241-116D8	111.06	12.55	1.37	0.37	0.37	0.25	0.00
Myoblast, donor2	11322-117D8	98.77	12.08	3.84	1.92	1.15	1.53	0.38
Myoblast, donor3	11398-118D3	173.71	21.69	0.17	0.17	0.00	0.67	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	116.02	25.10	2.33	1.61	1.02	1.46	0.44
Natural Killer Cells, donor1	11230-116C6	351.49	25.83	0.31	2.15	1.54	0.31	1.54
Natural Killer Cells, donor2	11311-117C6	253.91	15.68	3.32	5.13	4.52	0.60	2.11
Natural Killer Cells, donor3	11387-118C1	244.06	26.50	4.05	3.13	2.39	0.55	3.68
Neural stem cells, donor1	11275-116H6	528.08	38.83	3.27	2.18	0.73	1.09	0.73
Neural stem cells, donor2	11352-117H2	712.49	55.84	9.63	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	523.43	56.89	9.10	3.41	4.55	3.41	2.28
Neurons, donor2	11574-120E8	303.83	39.19	0.88	1.32	0.44	1.10	0.22
Neurons, donor3	11655-122E8	382.31	48.51	5.76	4.11	0.82	4.93	0.00
Neutrophils, donor1	11233-116C9	481.63	42.69	2.78	3.71	4.64	2.78	14.85
Neutrophils, donor2	11314-117C9	281.19	31.89	5.80	0.00	8.70	2.90	17.39
Neutrophils, donor3	11390-118C4	565.64	39.70	1.83	1.83	1.22	0.61	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	91.19	7.48	0.83	0.36	0.12	0.71	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	47.54	2.93	2.60	2.28	0.00	0.65	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	63.78	8.22	1.60	0.60	0.00	0.40	0.00
Olfactory epithelial cells, donor1	11933-125I7	48.18	5.37	0.83	0.41	0.41	0.14	0.41
Olfactory epithelial cells, donor2	11934-125I8	103.93	10.86	3.18	2.03	1.30	1.30	0.14
Olfactory epithelial cells, donor3	11935-125I9	68.10	8.74	1.25	0.57	0.68	0.57	0.34
Olfactory epithelial cells, donor4	11936-126A1	92.53	7.21	0.97	0.58	0.49	0.10	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	199.20	29.49	0.00	0.00	0.00	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	44.67	4.25	0.21	0.00	0.00	0.00	0.21
Osteoblast - differentiated, donor2	11353-117H3	29.72	2.29	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	31.66	4.34	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	58.24	7.04	0.00	0.20	0.20	0.00	0.20
Osteoblast, donor2	11354-117H4	415.07	41.44	2.11	3.51	2.11	2.11	0.00
Osteoblast, donor3	11426-118G4	70.20	9.95	0.53	0.36	0.53	0.36	0.18
Pancreatic stromal cells, donor1	11249-116E7	176.05	23.59	1.26	1.01	0.34	0.67	0.08
Pericytes, donor1	11491-119E6	21.92	1.67	0.00	0.00	0.00	0.00	0.11
Pericytes, donor2	11571-120E5	21.50	4.30	0.68	0.00	0.00	0.00	0.45
Pericytes, donor3	11652-122E5	28.28	3.66	0.61	0.20	0.00	0.00	0.00
Perineurial Cells, donor1	11499-119F5	225.59	24.86	1.02	0.34	0.68	0.45	0.23
Perineurial Cells, donor2	11579-120F4	158.72	19.05	0.64	0.37	0.18	0.28	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	389.82	28.37	0.32	0.64	0.00	1.27	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	194.42	19.34	1.96	3.18	1.22	0.49	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	203.57	18.89	1.42	0.91	0.91	0.52	0.39
Placental Epithelial Cells, donor1	11278-116H9	159.28	14.35	0.72	0.72	0.24	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	124.20	13.31	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	75.98	10.80	1.37	1.18	0.59	0.98	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	57.28	5.70	0.00	0.00	0.00	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	89.67	5.06	0.56	0.00	0.38	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	146.45	21.80	0.65	0.52	0.78	0.00	0.26
Preadipocyte - breast, donor2	11328-117E5	76.55	6.98	2.48	1.35	1.35	0.68	0.00
Preadipocyte - omental, donor1	11468-119C1	93.98	6.29	0.32	0.21	0.32	0.11	0.00
Preadipocyte - omental, donor2	11329-117E6	106.94	9.60	0.44	0.87	0.44	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	105.43	13.18	1.72	2.44	0.72	1.00	0.14
Preadipocyte - perirenal, donor1	11469-119C2	18.70	2.95	0.98	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	37.78	4.30	0.31	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	205.06	30.28	5.14	3.72	2.12	2.30	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	96.04	12.94	0.85	0.34	0.51	0.51	0.34
Preadipocyte - visceral, donor1	11280-116I2	285.78	35.68	1.02	0.93	0.47	1.12	0.37
Preadipocyte - visceral, donor2	11357-117H7	162.44	13.81	2.76	1.84	0.46	0.92	0.46
Preadipocyte - visceral, donor3	11429-118G7	119.54	15.88	1.57	1.36	0.52	0.94	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	332.63	39.07	2.56	2.41	0.91	2.41	0.15
Prostate Epithelial Cells, donor2	11331-117E8	52.27	7.04	0.68	0.81	0.81	0.27	0.27
Prostate Epithelial Cells, donor3	11404-118D9	117.39	14.39	3.86	2.33	1.47	1.47	0.18
Prostate Stromal Cells, donor1	11254-116F3	158.32	19.70	0.91	0.34	0.00	0.46	0.34
Prostate Stromal Cells, donor2	11332-117E9	158.86	17.21	7.89	2.87	1.08	3.05	0.90
Prostate Stromal Cells, donor3	11405-118E1	51.62	5.21	1.98	0.42	0.31	0.42	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	55.48	2.92	0.00	0.73	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	167.94	15.32	0.62	0.49	0.76	0.42	0.14
Renal Epithelial Cells, donor1	11517-119H5	36.52	2.03	0.51	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	36.99	4.98	0.00	0.71	0.00	0.71	0.71
Renal Epithelial Cells, donor3	11678-122H4	187.80	16.30	0.74	0.53	0.11	0.42	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	16.34	2.04	0.68	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	45.15	7.01	0.67	0.40	0.40	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	195.37	21.98	7.77	4.66	2.66	2.22	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	21.96	2.66	0.67	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	58.32	5.50	0.44	0.00	0.22	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	40.75	5.02	0.63	0.00	0.63	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	13.59	1.66	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	116.76	11.54	0.81	0.27	0.00	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	38.37	4.64	2.11	0.42	0.00	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	46.28	6.17	0.96	0.00	0.19	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	190.83	24.89	1.04	0.52	0.00	0.26	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	73.05	5.40	0.57	0.00	0.28	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	50.43	10.29	0.00	0.00	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	204.99	10.54	0.50	0.00	0.25	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	274.62	35.01	1.20	0.80	0.67	0.67	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	279.64	30.38	0.89	0.00	0.00	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	908.66	79.80	7.71	2.20	4.40	3.30	3.85
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	759.29	71.93	2.32	0.58	1.16	1.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	430.90	60.33	2.21	0.91	1.30	0.78	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	193.55	40.02	5.66	2.28	2.48	3.77	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	356.14	47.40	0.89	1.23	0.45	0.56	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	389.12	72.44	8.81	4.84	2.60	4.47	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	215.84	41.96	7.11	4.08	1.75	4.20	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	319.66	46.69	7.40	3.24	1.39	3.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	287.65	43.95	4.79	2.19	0.96	1.37	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	235.53	42.36	5.75	5.14	2.42	3.93	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	250.69	36.91	1.79	1.43	0.54	0.54	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	260.09	42.18	6.89	2.73	1.43	2.30	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	204.97	37.13	4.08	2.36	1.29	2.58	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	212.42	36.51	2.88	1.33	0.66	1.55	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	347.94	42.06	4.01	1.15	0.96	0.76	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	219.77	42.39	3.54	1.58	1.49	1.77	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	521.63	45.47	1.69	0.94	1.13	0.75	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	255.46	46.31	3.72	0.53	0.40	0.93	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	226.80	47.11	4.87	1.85	1.85	3.60	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	255.12	42.39	4.96	2.48	1.34	3.06	1.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	248.40	39.83	3.84	0.75	0.32	1.39	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	232.09	33.92	8.69	2.24	3.08	3.92	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	248.83	42.55	4.27	1.37	1.88	0.68	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	232.65	32.64	1.82	0.55	1.09	1.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	192.66	35.20	6.38	3.80	2.58	3.68	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	218.54	43.65	5.24	1.48	1.75	1.48	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	382.11	43.40	4.48	3.07	2.36	3.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	206.75	36.71	6.35	2.78	1.59	3.57	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	249.98	37.42	4.91	1.87	2.57	1.87	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	272.88	37.12	6.43	1.87	1.04	2.28	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	282.93	36.50	9.73	5.31	2.88	4.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	213.48	38.43	3.76	1.04	0.42	0.63	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	288.68	38.63	5.92	2.69	1.08	1.88	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	221.21	42.40	1.70	0.68	0.34	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	241.19	47.23	6.17	1.54	1.54	1.35	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	404.40	46.77	4.30	2.75	1.89	2.41	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	180.10	33.61	2.19	0.41	1.37	0.96	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	294.19	45.97	7.88	2.13	2.46	3.28	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	306.26	41.41	4.60	0.85	1.02	1.70	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	230.37	44.68	5.18	1.78	1.92	2.66	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	296.40	44.51	2.67	1.07	0.27	0.80	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	253.30	36.23	4.01	0.69	0.55	1.94	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	160.72	35.72	4.05	1.67	0.95	0.95	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	368.62	47.56	1.41	1.01	0.81	2.42	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	220.37	32.30	3.96	1.70	0.94	1.70	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	268.66	32.49	4.89	1.05	1.40	2.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	236.63	31.73	1.81	0.60	0.60	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	221.89	32.43	1.71	0.98	0.61	1.59	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	646.69	72.19	2.33	0.73	0.87	1.02	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	245.20	33.46	1.22	0.00	0.00	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	226.05	32.55	3.01	0.60	1.51	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	204.25	26.24	3.39	1.36	0.90	1.58	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	297.44	27.86	3.59	2.10	0.90	2.40	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	289.64	30.82	2.13	0.59	0.47	0.83	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	165.21	25.19	2.35	2.77	0.64	1.28	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	265.03	37.26	4.81	2.40	3.00	0.60	0.60
Schwann Cells, donor1	11498-119F4	48.52	6.39	0.75	0.19	0.19	0.19	0.19
Schwann Cells, donor2	11578-120F3	136.10	20.41	3.40	3.40	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	149.41	15.55	8.11	2.41	1.75	3.29	0.44
Sebocyte, donor1	11220-116B5	122.70	13.15	0.55	0.00	0.55	0.55	0.00
Sebocyte, donor2	11301-117B5	69.39	11.49	1.38	0.00	1.38	1.84	0.00
Sebocyte, donor3	11378-118B1	40.81	5.77	0.21	0.41	0.00	0.41	0.21
Sertoli Cells, donor1	11255-116F4	144.12	19.88	0.00	1.66	3.31	1.66	0.00
Sertoli Cells, donor2	11333-117F1	98.85	8.47	5.65	11.30	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	219.86	21.47	0.97	0.35	0.18	0.26	0.35
Skeletal Muscle Cells, donor2	11358-117H8	18.07	1.45	0.00	0.00	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	66.88	13.38	0.84	0.00	0.84	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	165.89	22.78	2.98	1.26	1.10	0.47	0.31
Skeletal Muscle Cells, donor5	11455-119A6	150.28	18.88	3.12	0.89	0.59	0.74	0.15
Skeletal Muscle Cells, donor6	11459-119B1	200.23	33.40	3.23	1.23	0.77	0.77	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	220.01	20.67	1.39	0.50	0.50	1.39	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	124.42	14.84	4.14	1.71	0.71	1.00	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	178.28	26.29	2.88	1.98	0.79	0.89	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	233.80	27.04	1.26	0.76	0.34	0.59	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	40.53	2.17	0.00	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	31.10	2.61	0.55	0.14	0.14	0.00	0.28
Skin - palm, donor1	10286-104F7	107.44	5.37	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	52.91	6.20	0.43	0.14	0.58	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	343.51	32.72	0.00	0.00	0.00	0.00	4.91
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	70.50	6.75	0.26	0.26	0.13	0.39	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	144.15	17.10	0.70	0.83	0.70	1.11	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	91.43	13.08	0.84	1.27	0.70	0.84	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	234.07	23.68	0.42	1.06	0.85	0.63	1.69
Small Airway Epithelial Cells, donor3	11406-118E2	108.23	18.89	2.25	1.42	0.97	0.45	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	128.68	11.73	1.85	1.23	0.93	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	117.84	15.34	1.33	1.33	0.00	0.89	1.33
Smooth Muscle Cells - Aortic, donor0	11210-116A4	44.67	7.05	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	45.52	4.86	0.22	0.66	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	40.95	7.09	0.00	0.00	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	61.81	7.73	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	135.10	6.00	3.00	1.00	1.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	42.19	5.72	0.00	0.13	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	77.80	11.97	1.55	2.22	0.44	1.33	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	36.87	8.96	0.51	0.26	0.13	0.00	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	98.00	17.91	0.65	0.33	0.00	0.00	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	100.71	16.24	0.30	0.00	0.30	0.00	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	45.98	7.69	0.28	0.57	0.00	0.28	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	29.44	3.09	0.00	0.00	0.00	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	93.77	7.31	0.91	0.30	0.30	1.22	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	36.62	3.79	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	32.42	2.86	0.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	117.39	13.13	0.44	0.15	0.59	0.15	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	100.73	12.91	1.94	1.94	0.22	0.22	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	125.32	18.26	1.89	1.15	0.84	0.94	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	38.82	4.95	0.00	0.15	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	17.25	3.23	0.00	1.08	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	34.37	8.97	0.60	0.30	0.00	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	43.02	6.83	1.37	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	172.92	12.88	1.18	0.71	0.47	0.55	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	111.81	9.76	0.91	0.60	0.30	0.40	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	85.33	12.06	3.19	1.37	0.23	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	30.79	3.62	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	444.02	55.37	2.91	0.79	1.06	0.79	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	205.33	28.36	1.73	0.00	0.40	0.27	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	91.03	12.40	2.63	1.63	0.38	0.50	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	54.79	2.79	0.25	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	102.07	14.47	0.75	0.15	0.15	0.30	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	28.51	1.50	0.75	0.00	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	140.85	19.38	1.29	2.58	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	43.25	4.65	0.00	0.47	0.00	0.93	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	54.53	8.58	0.00	0.50	0.50	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	21.62	2.19	0.31	0.31	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	17.40	0.88	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	402.87	45.65	0.92	0.25	0.42	0.33	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	78.48	6.54	1.40	0.00	0.47	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	35.12	5.04	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	43.34	7.90	0.51	0.51	0.00	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	38.55	5.08	0.38	0.38	0.38	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	324.91	37.59	0.84	0.70	0.28	0.70	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	110.43	13.41	0.34	0.25	0.25	0.25	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	14.76	0.48	0.00	0.00	0.00	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	33.03	3.91	0.49	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	92.80	11.49	0.44	0.22	0.00	0.44	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	122.88	14.63	0.29	0.29	0.29	0.88	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	69.78	5.05	0.58	0.19	0.00	0.19	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	97.85	9.26	1.06	0.53	1.59	1.06	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	146.92	16.74	1.86	1.49	0.37	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	97.02	8.98	0.72	1.44	1.44	0.36	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	82.05	9.37	0.28	0.28	0.28	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	309.97	32.30	2.76	0.79	1.58	3.15	1.58
Smooth muscle cells - airway, control, donor1	11966-126D4	87.36	8.38	1.27	0.76	1.52	0.51	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	64.29	4.79	0.80	0.40	0.00	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	54.34	2.93	0.00	0.84	0.00	0.42	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	74.71	10.08	1.83	0.46	0.46	0.46	0.46
Synoviocyte, donor1	11291-117A4	134.82	10.94	1.51	0.50	0.34	1.01	0.17
Synoviocyte, donor2	11368-117I9	55.48	5.03	1.51	0.00	0.34	1.01	1.01
Synoviocyte, donor3	11440-118H9	57.86	7.82	0.89	0.22	0.00	0.45	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	126.14	13.58	0.36	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	49.55	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	46.77	6.25	0.23	0.00	0.00	0.00	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	99.71	11.33	0.29	0.00	0.14	0.00	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	24.74	4.25	0.00	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	26.92	2.29	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	281.85	32.48	2.46	0.49	0.37	0.37	0.00
Urethra, donor2	10319-105A4	203.22	17.98	0.00	5.40	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	30.29	4.78	0.53	0.00	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	22.83	3.20	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	18.57	2.52	0.69	0.23	0.23	0.23	0.00
Urothelial cells, donor0	11216-116B1	132.85	18.95	1.34	0.67	0.67	0.45	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	445.78	39.15	1.78	0.00	0.89	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	510.37	50.04	2.86	2.86	1.43	2.86	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	188.24	18.48	4.11	0.68	0.00	2.05	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	283.73	23.07	2.07	1.38	1.03	0.34	1.72
Whole blood (ribopure), donor090325, donation2	12177-128I8	282.96	18.01	2.32	1.16	0.58	1.74	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	455.02	23.95	2.08	2.08	1.04	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	453.39	38.55	2.75	2.75	0.00	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	179.84	13.69	6.39	1.83	0.91	1.83	0.91
Wilms' tumor cell line:G-401	10809-111A8	243.39	35.65	2.84	1.48	1.11	1.11	0.12
Wilms' tumor cell line:HFWT	10597-108E3	112.65	10.56	2.64	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	221.50	27.93	1.68	1.68	1.12	1.12	1.68
achilles tendon, donor2	10292-104G4	132.26	12.40	2.07	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	293.45	40.54	3.06	2.04	1.78	1.78	1.53
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	411.65	62.92	0.93	2.09	1.39	1.86	2.09
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	464.03	70.63	2.37	1.90	0.47	2.26	1.66
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	393.48	62.04	2.99	3.27	1.36	2.99	3.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	234.99	36.26	11.81	5.90	3.65	4.78	2.25
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	331.60	37.64	1.27	2.33	0.85	0.42	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	247.71	22.32	1.91	2.18	1.36	1.91	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	305.36	33.93	2.64	3.53	2.20	2.64	2.64
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	288.30	38.79	8.17	4.08	3.68	3.27	3.27
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	243.85	46.60	4.27	4.27	2.33	3.11	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	266.98	31.65	8.10	5.15	2.94	3.68	0.92
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	226.23	31.20	0.00	0.00	0.00	3.90	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	275.37	41.13	5.81	3.25	2.09	3.02	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	361.69	54.11	5.95	5.70	3.37	5.95	3.37
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	336.37	46.17	15.78	14.03	5.55	4.09	2.34
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	233.31	28.35	5.11	0.93	0.00	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	195.76	26.32	3.70	1.23	0.82	0.41	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	36.22	5.83	0.61	0.00	0.00	0.61	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	213.78	37.55	0.85	2.13	0.43	0.43	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	210.18	35.79	0.91	0.91	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	226.02	34.90	0.48	0.48	0.48	1.20	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	265.73	34.97	4.23	4.01	2.90	2.67	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	338.88	30.69	3.34	1.33	1.00	1.67	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	696.83	104.06	3.72	1.86	0.00	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	341.25	47.46	2.64	1.88	1.88	4.14	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	315.32	47.54	3.05	0.44	0.87	1.74	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	461.12	108.72	1.87	0.00	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	103.38	18.37	0.71	0.00	0.24	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	213.60	15.82	1.40	0.31	0.47	0.93	0.00
adipose, donor1	10184-103D4	1778.58	151.88	27.56	18.18	11.14	11.73	5.86
adipose, donor2	10185-103D5	218.17	14.60	2.43	6.49	1.22	0.81	2.84
adipose, donor3	10186-103D6	260.85	25.60	2.72	1.91	0.82	4.08	1.63
adipose, donor4	10187-103D7	370.97	45.07	8.67	6.07	6.07	4.33	5.20
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	270.82	54.92	2.84	0.79	1.10	0.95	0.63
adrenal gland, adult, pool1	10081-102A9	61.84	7.28	0.00	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	201.44	30.95	1.47	0.80	0.80	0.80	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	221.53	35.37	4.29	2.50	1.79	2.14	1.79
amniotic membrane cells, donor1	12235-129G3	168.55	15.77	1.16	0.70	0.23	0.70	0.00
amniotic membrane cells, donor2	12236-129G4	134.57	15.55	0.34	1.35	0.34	0.34	0.34
amniotic membrane cells, donor3	12237-129G5	179.41	12.37	1.77	0.88	0.88	0.88	0.00
amygdala - adult, donor10196	10167-103B5	313.05	17.79	8.30	2.37	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	270.09	32.85	5.68	3.04	1.62	0.81	0.41
amygdala, newborn, donor10223	10360-105E9	210.45	18.08	1.29	0.97	2.26	1.61	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	181.57	11.21	1.15	0.64	0.13	0.64	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	155.54	35.30	0.66	1.99	1.54	0.88	1.32
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	276.25	46.10	3.01	2.67	1.34	3.67	3.34
aorta, adult, pool1	10052-101G7	145.33	15.30	2.75	0.98	0.78	0.59	0.59
appendix, adult	10189-103D9	208.42	20.18	2.33	1.55	0.00	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	249.35	54.34	4.13	1.03	0.69	0.34	3.44
artery, adult	10190-103E1	148.10	16.30	4.08	1.36	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	205.13	32.02	1.16	0.72	1.01	0.43	0.29
b cell line:RPMI1788	10427-106D4	194.20	29.15	0.74	0.59	0.45	0.59	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	85.73	10.27	0.83	0.28	0.28	0.28	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	212.55	31.26	0.89	0.69	0.50	0.50	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	157.84	23.94	1.00	1.17	0.67	1.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	120.80	16.78	1.68	0.00	1.12	2.24	1.68
bladder, adult, pool1	10011-101C2	268.24	17.38	1.52	0.54	0.33	0.87	0.00
blood, adult, pool1	10053-101G8	106.30	13.29	0.00	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	166.13	24.83	0.86	0.00	0.00	0.86	0.00
bone marrow, adult	10192-103E3	230.79	22.94	7.42	6.07	0.67	2.70	0.00
brain, adult, donor1	10084-102B3	78.93	12.30	0.00	1.03	1.03	0.00	0.00
brain, adult, pool1	10012-101C3	190.87	21.71	1.34	0.45	0.11	0.67	0.11
brain, fetal, pool1	10085-102B4	82.81	13.36	0.00	2.67	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	235.55	28.74	2.31	2.97	1.98	2.64	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	255.14	25.59	0.50	0.25	0.12	0.50	0.00
breast, adult, donor1	10080-102A8	164.15	15.78	1.89	0.00	3.79	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	135.30	40.65	3.94	2.16	1.78	0.76	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	95.24	25.36	1.55	1.24	0.62	0.93	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	253.47	25.55	1.84	1.84	0.69	1.38	3.22
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	193.67	31.23	4.12	3.15	2.66	1.45	1.21
carcinoid cell line:NCI-H1770	10703-109H1	206.40	28.21	4.23	2.35	1.88	1.41	2.82
carcinoid cell line:NCI-H727	10735-110B6	210.23	35.55	0.44	0.66	0.66	0.11	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	208.83	39.61	3.80	2.85	2.22	0.95	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	529.16	48.71	18.63	6.92	6.39	4.26	2.40
caudate nucleus - adult, donor10196	10177-103C6	439.81	44.90	2.30	1.15	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	272.74	37.48	4.85	2.01	2.34	0.84	0.00
caudate nucleus, adult, donor10258	10379-105H1	193.33	16.05	1.53	0.00	0.00	1.53	0.00
caudate nucleus, newborn, donor10223	10354-105E3	292.25	15.02	1.46	1.46	0.00	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	550.61	58.27	5.83	0.00	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	414.21	41.85	9.18	4.91	2.35	1.92	0.85
cerebellum, adult, pool1	10083-102B2	137.63	16.56	2.76	1.72	1.03	0.00	0.69
cerebellum, newborn, donor10223	10357-105E6	577.88	37.36	4.98	4.98	0.83	0.83	0.00
cerebral meninges, adult	10188-103D8	158.60	24.46	2.27	2.77	1.01	0.76	0.00
cerebrospinal fluid, donor2	10294-104G6	121.33	8.77	2.19	2.92	0.73	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	439.11	63.55	1.44	1.15	0.72	1.01	0.14
cervical cancer cell line:ME-180	10553-107I4	408.82	46.40	1.66	1.16	0.33	1.16	0.33
cervix, adult, pool1	10013-101C4	286.52	20.79	1.78	0.73	0.73	0.42	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	109.10	16.16	0.28	0.56	0.28	0.56	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	70.54	9.14	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	422.04	40.27	2.49	1.12	2.24	1.37	1.12
choriocarcinoma cell line:SCH	10785-110H2	244.70	29.69	3.08	3.08	3.45	1.72	0.86
choriocarcinoma cell line:T3M-3	10618-108G6	290.78	29.41	1.90	0.00	0.24	0.71	0.00
chorionic membrane cells, donor1	12238-129G6	149.58	19.09	1.42	2.56	0.00	0.57	0.28
chorionic membrane cells, donor2	12239-129G7	153.52	19.19	0.99	0.80	0.20	0.40	0.00
chorionic membrane cells, donor3	12240-129G8	165.94	20.88	4.95	4.40	2.20	1.10	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	297.89	55.54	15.15	8.08	1.01	4.04	4.04
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	172.50	26.70	0.58	1.73	0.38	0.19	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	274.12	33.79	3.80	1.06	0.63	0.42	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	382.38	43.91	4.11	3.34	1.80	1.03	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	403.45	49.59	2.42	1.69	1.21	1.21	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	457.92	53.96	2.24	1.83	1.22	1.63	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	469.07	58.60	4.12	1.77	0.88	0.29	1.77
chronic myelogenous leukemia cell line:KU812	10409-106B4	334.90	52.13	0.26	1.04	1.30	0.26	1.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	138.06	23.32	4.57	2.29	2.74	1.60	1.60
clear cell carcinoma cell line:TEN	10636-108I6	172.47	15.27	1.21	0.87	0.35	0.52	0.00
colon carcinoma cell line:CACO-2	10513-107D9	385.85	42.47	1.65	2.20	0.73	0.00	1.10
colon carcinoma cell line:COLO-320	10420-106C6	508.93	68.03	2.66	0.76	0.76	1.52	0.38
colon, adult, donor1	10082-102B1	107.10	19.04	1.19	0.00	1.19	1.19	0.00
colon, adult, pool1	10014-101C5	211.39	20.21	0.35	0.71	0.47	0.24	0.12
colon, fetal, donor1	10070-101I7	181.07	21.01	1.24	1.24	1.24	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	128.34	13.75	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	150.22	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	539.66	52.27	2.55	3.40	2.55	0.85	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	284.35	36.53	0.91	1.51	0.91	1.36	1.06
cord blood derived cell line:COBL-a untreated	10449-106F8	320.94	40.75	1.55	1.41	0.28	0.28	1.13
corpus callosum, adult, pool1	10042-101F6	352.03	35.71	1.66	1.00	0.66	0.44	0.22
cruciate ligament, donor2	10295-104G7	187.22	17.83	4.05	3.24	0.00	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	150.08	11.24	1.61	0.80	0.00	0.00	0.00
diencephalon, adult	10193-103E4	203.27	19.92	2.64	0.48	2.16	0.72	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	351.31	42.48	13.55	13.78	6.43	7.12	6.66
ductal cell carcinoma cell line:KLM-1	10438-106E6	334.91	24.11	1.03	0.77	0.26	0.00	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	181.26	19.02	0.48	1.20	1.44	0.24	0.48
ductus deferens, adult	10196-103E7	174.42	23.92	4.98	0.50	1.50	0.50	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	129.62	15.84	5.76	1.44	2.88	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	317.06	24.28	7.36	7.36	5.89	2.94	0.00
dura mater, adult, donor1	10041-101F5	170.63	16.68	0.08	0.08	0.33	0.00	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	319.78	30.42	1.11	0.89	0.67	0.00	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	295.47	27.80	2.15	1.15	0.14	0.29	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	175.12	19.73	1.85	0.62	0.62	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	117.45	10.90	1.51	0.91	1.51	0.61	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	163.33	18.52	0.62	1.23	0.31	0.93	0.93
embryonic pancreas cell line:2C6	10603-108E9	208.84	18.39	1.31	0.00	3.94	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	168.94	17.09	0.34	0.00	0.67	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	228.72	31.72	2.36	2.72	1.99	1.81	1.99
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	110.16	11.90	2.09	1.77	1.29	1.13	0.48
epidermoid carcinoma cell line:A431	10426-106D3	338.81	40.24	0.89	0.22	0.78	0.22	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	321.60	39.15	1.43	0.66	0.66	1.21	0.22
epididymis, adult	10197-103E8	123.28	14.65	2.30	1.26	1.67	0.21	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	213.96	25.37	2.13	1.24	1.42	1.77	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	151.40	16.91	1.18	0.00	0.39	1.18	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	264.20	37.74	6.81	3.01	1.83	2.49	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	246.84	39.76	3.94	2.07	1.87	2.76	0.59
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	230.22	37.53	5.38	2.69	3.14	1.57	1.34
esophagus, adult, pool1	10015-101C6	174.88	19.54	1.91	0.32	0.53	1.06	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	377.34	43.46	0.63	0.75	0.50	0.50	0.25
eye - muscle inferior rectus, donor1	10272-104E2	195.58	4.83	7.24	2.41	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	140.98	8.42	6.31	0.00	2.10	2.10	2.10
eye - muscle medial, donor2	10299-104H2	107.15	8.93	7.44	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	158.22	11.46	3.44	2.29	2.29	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	96.19	17.49	2.91	0.00	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	232.62	25.93	4.83	3.05	2.29	1.78	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	168.23	29.11	2.18	2.05	1.67	1.54	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	246.68	43.69	4.99	3.09	1.42	1.66	1.90
frontal lobe, adult, pool1	10040-101F4	246.48	24.02	1.60	0.38	0.19	0.56	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	271.12	42.03	3.30	4.20	1.20	2.40	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	203.35	26.61	0.73	0.37	0.55	0.46	0.00
gall bladder, adult	10198-103E9	114.68	13.52	1.69	0.97	0.48	0.24	0.48
gamma delta positive T cells, donor1	11937-126A2	239.44	13.42	0.54	0.54	0.00	0.00	1.07
gamma delta positive T cells, donor2	11938-126A3	217.37	11.95	0.75	1.12	0.75	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	140.04	19.64	4.22	2.96	2.11	3.17	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	207.34	32.69	7.16	1.16	2.71	1.93	0.97
gastric cancer cell line:AZ521	10549-107H9	461.53	63.12	2.13	0.33	0.82	0.98	0.66
gastric cancer cell line:GSS	10560-108A2	277.31	21.05	0.00	0.92	2.75	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	358.91	29.01	10.51	5.48	3.43	4.80	0.91
giant cell carcinoma cell line:LU65	10487-107B1	295.23	45.78	1.49	1.95	0.57	0.69	0.92
giant cell carcinoma cell line:Lu99B	10433-106E1	130.16	12.04	0.84	0.14	0.14	0.14	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	329.98	44.90	5.49	2.74	1.50	1.25	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	182.61	29.55	0.53	0.42	0.42	0.42	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	176.81	30.62	0.56	0.00	0.84	0.70	0.28
glioblastoma cell line:T98G	10485-107A8	191.50	33.55	0.77	0.66	0.33	1.21	0.44
glioma cell line:GI-1	10413-106B8	143.80	26.36	0.59	0.00	0.00	0.29	0.59
globus pallidus - adult, donor10196	10175-103C4	349.88	35.72	2.92	1.46	3.64	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	443.52	50.53	7.08	3.66	2.44	2.20	0.00
globus pallidus, adult, donor10258	10367-105F7	223.18	12.32	1.37	0.00	1.37	5.48	0.00
globus pallidus, newborn, donor10223	10364-105F4	173.73	7.99	0.00	0.00	0.53	0.53	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	68.52	4.89	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	153.00	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	88.85	10.45	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	126.72	14.08	1.92	0.32	0.64	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	489.42	49.58	8.72	0.46	2.30	0.92	0.46
hIPS +CCl2, biol_rep2	14384-156C1	510.76	49.38	5.94	4.12	1.37	1.37	0.91
hIPS +CCl2, biol_rep3	14385-156C2	531.38	52.82	7.73	0.64	1.93	0.64	0.64
hIPS, biol_rep1	14380-156B6	789.07	60.37	10.06	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	392.32	38.41	8.23	1.37	4.12	2.74	0.00
hIPS, biol_rep3	14382-156B8	227.31	33.10	8.83	1.10	1.10	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	172.69	25.57	4.02	2.87	2.59	3.45	2.59
heart - mitral valve, adult	10205-103F7	238.88	19.13	4.78	2.39	2.09	0.90	0.30
heart - pulmonic valve, adult	10206-103F8	224.87	28.76	4.45	1.31	0.78	0.78	1.05
heart - tricuspid valve, adult	10207-103F9	268.11	27.48	5.00	1.67	1.67	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	111.21	18.37	2.86	2.65	1.02	1.43	0.82
heart, adult, diseased, donor1	10051-101G6	66.43	8.52	1.28	1.28	0.00	0.43	0.00
heart, adult, pool1	10016-101C7	105.10	12.42	0.46	0.23	0.23	0.23	0.00
heart, fetal, pool1	10046-101G1	322.42	47.23	1.13	0.51	0.72	0.41	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	99.65	17.28	0.62	0.31	1.23	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	297.29	42.81	0.00	2.38	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	228.73	37.46	4.31	1.99	1.77	2.54	0.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	233.16	39.33	6.92	3.03	2.18	2.67	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	266.58	42.54	3.64	3.03	1.41	2.02	0.30
hepatoma cell line:Li-7	10484-107A7	207.53	30.14	0.78	1.11	0.67	1.00	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	238.79	47.84	2.61	1.71	1.61	2.01	0.30
hippocampus - adult, donor10196	10169-103B7	299.99	30.28	5.68	5.68	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	326.76	40.21	8.98	4.29	1.22	1.63	0.82
hippocampus, adult, donor10258	10374-105G5	322.17	18.92	0.50	1.00	0.50	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	149.45	11.63	0.00	1.06	0.70	0.35	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	968.01	83.62	7.93	9.16	7.32	6.10	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	388.39	35.93	5.11	5.50	1.37	1.57	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	513.38	43.67	3.55	5.08	2.03	4.32	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	471.39	26.50	3.95	1.69	0.56	2.82	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	460.13	35.12	24.53	15.49	7.23	11.62	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	652.55	38.34	7.97	3.04	1.14	0.38	2.28
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	388.59	28.90	2.63	4.67	1.46	0.29	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	346.41	34.68	3.88	4.95	1.51	1.51	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	330.32	25.44	0.42	1.25	0.42	2.09	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	478.56	41.91	3.79	3.55	0.95	0.47	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	356.47	37.61	4.66	3.86	1.93	1.45	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	430.24	39.05	0.67	0.67	0.67	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	306.87	33.80	4.07	4.38	2.03	1.56	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	399.42	43.23	15.72	14.25	5.40	6.88	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	909.41	51.49	6.11	6.11	1.75	2.62	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	582.47	46.39	4.39	2.67	2.29	1.15	0.76
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	601.34	41.86	9.59	2.18	2.18	3.05	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	910.07	63.97	7.50	8.00	4.00	2.00	4.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	425.76	35.98	5.46	3.77	3.96	2.45	1.32
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	470.18	32.28	8.18	2.27	0.91	2.27	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	472.05	25.69	3.76	2.51	1.88	1.25	2.51
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	324.97	29.56	5.06	3.27	2.29	1.80	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	329.21	31.06	3.77	3.19	0.58	1.16	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	295.04	22.12	3.59	0.60	1.49	1.20	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	448.38	43.05	9.79	6.84	2.22	2.59	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	409.38	40.23	6.28	2.85	0.86	1.14	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	721.49	69.41	7.76	6.12	2.04	2.04	2.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	605.93	47.53	13.38	9.15	4.22	5.63	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	506.47	40.86	6.02	1.58	1.58	2.22	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	522.32	35.10	5.14	3.03	1.82	1.51	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	387.32	34.65	3.62	0.52	1.03	0.52	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	427.72	31.88	3.98	0.00	0.66	1.33	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	391.47	28.73	2.31	0.77	1.80	0.77	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	326.46	37.58	6.39	3.58	1.79	2.81	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	407.39	29.53	5.30	0.00	1.51	3.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	322.62	30.25	2.69	2.69	1.01	1.01	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	482.29	44.44	7.25	3.86	1.45	2.17	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	746.03	54.37	8.91	5.35	1.78	0.89	2.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	496.59	39.51	4.39	2.93	1.95	0.98	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	681.53	49.82	7.95	4.28	1.53	2.14	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	9440.91	572.57	113.86	74.82	45.55	29.28	16.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	963.70	61.22	7.61	4.63	2.32	3.97	1.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	506.80	33.93	2.74	2.74	2.74	2.74	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	440.78	36.55	2.53	2.90	1.09	1.81	2.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	413.17	32.38	3.20	2.14	0.36	0.71	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	467.81	33.41	3.58	7.16	1.19	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	530.19	51.33	1.76	1.76	0.68	0.54	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	304.42	29.90	1.62	1.89	1.35	0.27	0.81
immature langerhans cells, donor1	11904-125F5	303.65	25.67	0.48	1.21	0.24	0.00	0.97
immature langerhans cells, donor2	11905-125F6	139.42	19.80	3.17	1.58	0.79	0.00	0.00
insula, adult, pool1	10039-101F3	238.38	23.19	0.57	0.28	0.19	0.57	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	88.44	13.98	0.65	0.65	0.33	0.00	0.65
kidney, adult, pool1	10017-101C8	227.09	15.92	2.20	1.20	0.60	0.60	0.00
kidney, fetal, pool1	10045-101F9	210.51	17.33	1.06	0.35	0.28	0.07	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	227.94	36.36	0.71	0.43	0.43	0.43	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	67.05	8.71	1.38	0.69	0.55	0.00	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	309.75	33.76	1.10	1.10	0.73	1.47	0.18
left atrium, adult, donor1	10079-102A7	55.03	7.63	2.18	1.09	1.09	0.54	0.00
left ventricle, adult, donor1	10078-102A6	85.96	13.65	3.03	0.51	1.01	1.01	0.51
leiomyoblastoma cell line:G-402	10721-110A1	134.34	22.98	1.37	0.55	1.09	0.55	0.27
leiomyoma cell line:10964C	10569-108B2	35.57	2.87	2.16	0.36	0.00	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	50.54	4.35	1.63	0.00	0.00	0.54	0.00
leiomyoma cell line:15425	10571-108B4	76.49	8.26	1.70	2.43	1.46	0.97	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	95.24	6.35	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	188.20	25.09	0.00	1.05	0.00	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	214.98	42.50	3.19	1.18	1.30	1.06	0.83
liposarcoma cell line:KMLS-1	10782-110G8	118.09	15.78	0.94	0.78	0.47	0.31	0.62
liposarcoma cell line:SW 872	10726-110A6	172.04	33.87	1.34	1.10	0.85	0.85	1.22
liver, adult, pool1	10018-101C9	94.16	13.29	0.32	0.16	0.65	0.00	0.00
liver, fetal, pool1	10086-102B5	29.16	6.58	0.00	0.00	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	264.82	24.35	2.48	1.31	0.44	0.87	0.00
locus coeruleus, adult, donor10252	10165-103B3	277.38	33.77	3.88	2.95	1.48	2.03	0.18
locus coeruleus, adult, donor10258	10375-105G6	118.78	11.29	0.56	0.28	0.85	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	597.70	37.86	4.21	3.36	0.84	2.52	0.42
lung adenocarcinoma cell line:A549	10499-107C4	150.71	23.53	0.97	0.42	0.14	0.69	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	268.18	43.43	0.00	0.00	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	148.82	41.26	0.66	0.53	0.79	0.26	0.13
lung, adult, pool1	10019-101D1	183.81	19.73	0.83	0.24	0.24	0.59	0.00
lung, fetal, donor1	10068-101I5	1002.35	88.48	3.14	0.86	1.14	0.86	0.00
lung, right lower lobe, adult, donor1	10075-102A3	101.27	19.25	1.83	0.92	1.83	2.29	0.00
lymph node, adult, donor1	10077-102A5	69.58	5.21	1.42	0.47	0.00	1.42	0.47
lymphangiectasia cell line:DS-1	10727-110A7	100.38	19.29	0.44	0.44	0.00	1.53	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	233.79	25.05	1.66	1.96	0.45	0.91	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	571.71	62.01	2.55	0.85	0.00	0.85	1.70
mature adipocyte, donor1	12231-129F8	133.20	10.66	0.89	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	163.53	16.81	0.83	0.00	0.00	0.21	0.42
mature adipocyte, donor3	12233-129G1	180.88	12.56	0.24	0.24	0.00	0.24	0.00
mature adipocyte, donor4	12234-129G2	265.59	17.11	0.00	1.05	0.26	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	322.84	43.84	0.95	0.24	0.00	0.95	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	238.01	27.07	2.26	3.38	2.26	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	300.69	30.16	6.99	2.21	1.66	1.47	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	152.81	12.07	3.18	0.95	2.22	1.27	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	531.83	48.19	2.99	3.84	1.28	3.41	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	252.28	24.13	12.99	6.75	4.56	5.23	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	342.32	31.20	5.73	4.67	1.27	2.33	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	489.27	13.48	1.93	0.00	1.93	1.93	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	3990.30	516.73	114.83	71.77	43.06	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	164.03	18.31	0.72	0.72	0.72	0.36	0.36
medulla oblongata - adult, donor10196	10174-103C3	311.51	30.50	1.30	2.60	1.30	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	319.98	36.69	5.26	2.48	1.86	1.55	0.15
medulla oblongata, adult, pool1	10038-101F2	266.51	27.51	1.31	0.57	0.65	0.33	0.16
medulla oblongata, newborn, donor10223	10361-105F1	240.25	14.23	3.82	1.04	1.04	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	495.96	66.20	11.51	9.52	5.31	3.99	1.77
medulloblastoma cell line:ONS-76	10759-110E3	174.12	31.30	2.45	0.49	1.22	0.73	0.49
melanoma cell line:COLO 679	10514-107E1	100.33	23.14	0.43	0.43	0.14	0.00	0.29
melanoma cell line:G-361	10465-106H6	110.76	19.82	0.81	0.54	0.81	0.81	0.00
meningioma cell line:HKBMM	10691-109F7	80.68	9.41	3.08	2.35	0.54	0.72	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	562.18	74.90	11.46	8.81	6.17	12.34	4.41
merkel cell carcinoma cell line:MS-1	10844-111E7	260.52	53.14	2.85	3.63	2.33	1.04	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	127.96	17.49	2.45	1.07	0.46	0.46	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	91.25	15.63	1.82	0.73	0.36	0.55	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	125.06	14.49	1.66	0.41	0.41	2.07	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	70.94	9.27	1.55	0.70	0.14	0.28	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	67.40	9.24	1.73	0.58	0.39	0.19	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	69.41	11.11	0.69	0.69	1.39	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	47.54	5.84	2.40	0.00	0.00	0.17	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	59.46	8.63	2.30	0.81	0.46	0.46	0.69
mesenchymal precursor cell - cardiac, donor3	11754-123G8	117.78	19.50	1.59	0.80	0.66	0.80	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	116.40	19.58	2.03	0.54	1.08	0.81	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	105.99	15.65	2.28	1.28	0.28	1.00	0.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	85.63	9.55	0.33	1.65	0.00	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	88.56	11.62	1.52	0.00	0.55	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	116.24	17.45	4.19	2.44	2.09	1.05	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	67.37	9.19	0.82	0.61	0.82	0.61	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	73.33	7.55	0.72	0.72	0.00	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	48.10	6.52	1.03	0.10	0.10	0.10	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	39.67	7.98	1.14	0.91	0.00	0.23	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	245.02	43.63	4.62	3.36	1.26	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	68.74	11.96	1.20	0.75	0.75	0.60	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	76.85	12.17	1.66	0.26	0.44	0.44	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	102.72	9.57	1.47	1.10	0.37	1.10	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	69.25	6.87	0.86	3.43	0.57	0.00	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	270.29	26.10	11.37	7.16	3.37	5.05	2.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	114.17	10.05	3.20	0.00	0.91	1.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	132.50	15.35	0.77	0.51	0.51	1.28	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	140.04	14.66	2.09	0.26	0.26	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	122.62	9.55	2.77	1.54	0.62	2.77	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	138.62	14.83	3.53	0.94	0.94	1.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	142.15	15.91	0.68	0.34	0.68	0.68	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	132.43	9.04	3.14	0.79	1.18	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	151.99	10.66	1.85	1.39	0.93	3.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	483.04	0.00	0.00	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	172.47	15.29	1.73	0.87	0.58	0.87	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	135.65	12.94	1.12	0.22	0.22	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	134.12	14.66	2.40	0.96	0.96	0.48	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	195.80	15.40	2.20	0.73	0.73	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	123.52	7.72	1.34	1.01	0.00	1.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	145.33	13.10	2.87	2.05	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	157.65	8.59	1.29	1.29	0.86	1.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	120.31	16.41	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	108.46	5.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	109.45	11.04	1.62	0.97	0.65	0.32	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	107.67	13.09	1.45	1.45	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	99.69	9.06	0.53	1.07	2.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	82.59	5.72	1.64	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	103.79	7.77	1.94	1.17	0.00	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	115.43	8.39	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	95.37	3.97	0.99	0.00	0.99	3.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	76.28	9.53	9.53	4.77	4.77	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	91.91	9.49	2.37	2.37	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	71.89	7.31	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	108.21	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	95.01	10.13	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	64.15	5.86	1.03	0.34	0.69	0.34	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	53.73	0.00	0.00	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	87.82	0.00	11.98	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	99.87	3.44	3.44	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	57.05	4.07	3.26	0.81	0.41	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	62.76	6.36	3.18	0.79	1.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	50.70	1.77	0.59	0.59	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	58.29	4.68	1.25	0.62	0.00	0.94	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	61.49	5.35	0.00	0.00	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	73.33	2.37	1.18	1.18	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	69.34	7.70	10.27	10.27	2.57	5.14	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	83.98	12.39	4.13	1.38	0.00	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	73.23	10.39	0.99	0.49	1.48	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	70.65	6.73	3.36	0.00	0.00	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	64.88	8.90	1.91	0.00	0.64	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	47.55	4.84	0.81	0.00	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	45.79	6.54	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	40.55	2.53	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	58.26	11.53	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	54.23	4.52	4.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	65.07	8.24	3.29	0.82	0.00	2.47	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	94.05	6.15	0.20	0.20	0.20	0.00	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	86.96	7.46	1.30	0.65	0.32	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	92.70	11.20	4.07	2.04	1.02	2.04	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	150.87	6.19	0.00	0.77	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	220.65	38.27	0.47	0.00	0.71	0.47	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	180.01	25.95	0.70	0.23	0.70	0.46	0.93
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	98.29	8.55	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	136.45	12.95	0.82	0.31	0.51	0.72	0.31
mesothelioma cell line:Mero-25	10850-111F4	157.51	12.71	1.82	1.82	2.27	1.13	0.00
mesothelioma cell line:Mero-41	10851-111F5	159.40	16.62	2.20	0.98	1.71	0.49	0.00
mesothelioma cell line:Mero-48a	10852-111F6	152.12	20.81	3.54	2.88	1.11	1.11	0.66
mesothelioma cell line:Mero-82	10853-111F7	204.20	24.44	7.62	4.99	2.63	3.15	1.58
mesothelioma cell line:Mero-83	10854-111F8	198.65	26.55	5.79	2.38	2.38	3.06	0.85
mesothelioma cell line:Mero-84	10855-111F9	109.45	7.58	0.76	0.00	0.25	0.51	0.00
mesothelioma cell line:Mero-95	10856-111G1	167.70	13.25	2.28	1.86	0.83	1.24	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	175.92	20.87	2.65	2.32	1.66	2.98	1.16
mesothelioma cell line:NCI-H226	10846-111E9	180.45	24.98	5.61	2.35	2.17	2.17	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	179.88	19.30	2.22	3.25	1.20	1.37	0.34
mesothelioma cell line:NCI-H28	10845-111E8	109.93	17.81	2.80	1.78	0.76	0.25	0.51
mesothelioma cell line:No36	10857-111G2	163.10	8.81	2.28	1.96	0.33	0.33	0.98
mesothelioma cell line:ONE58	10858-111G3	209.72	15.44	3.79	1.63	1.35	1.63	1.08
migratory langerhans cells, donor1	11901-125F2	186.74	22.26	1.15	1.15	0.19	0.00	0.58
migratory langerhans cells, donor2	11902-125F3	151.91	13.43	0.49	0.61	0.12	0.24	0.73
migratory langerhans cells, donor3	11903-125F4	203.17	16.51	0.36	0.72	0.36	0.00	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	168.14	20.24	7.18	6.20	1.96	3.26	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	78.84	29.25	2.12	1.91	0.42	0.85	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	259.61	42.62	1.38	0.46	0.46	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	141.20	28.92	1.52	0.57	1.14	0.76	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	319.32	48.60	2.96	1.66	2.03	0.74	0.37
myeloma cell line:PCM6	10474-106I6	47.84	7.51	0.40	0.20	0.20	0.20	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	155.74	9.64	1.52	0.00	1.01	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	105.52	15.30	1.37	0.98	0.98	0.98	1.18
nasal epithelial cells, donor1, tech_rep1	12226-129F3	119.67	13.71	0.45	0.33	0.56	0.22	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	150.54	15.15	0.44	0.74	0.29	0.07	0.22
nasal epithelial cells, donor2	12227-129F4	73.97	7.18	0.55	0.00	0.00	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	556.06	86.50	0.69	2.53	0.46	0.46	0.46
neuroblastoma cell line:NB-1	10539-107G8	541.80	89.99	3.74	1.87	0.94	1.87	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	335.10	47.66	9.91	4.22	1.05	2.32	1.27
neuroblastoma cell line:NH-12	10555-107I6	536.69	48.45	8.94	4.47	3.35	3.91	1.68
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	246.24	24.67	8.78	5.46	3.08	2.37	4.03
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	217.46	34.05	3.01	2.69	1.43	1.27	2.22
neuroectodermal tumor cell line:TASK1	10774-110F9	113.51	21.13	1.81	0.60	0.40	1.01	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	117.62	20.34	0.00	0.00	0.00	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	132.82	15.17	0.80	0.53	0.53	0.53	0.00
neutrophil PMN, donor1	12133-128D9	89.25	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	172.65	13.28	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	123.12	9.47	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	568.08	77.46	1.86	3.38	1.69	1.69	1.18
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	193.72	44.03	1.60	2.40	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	101.31	14.75	2.24	0.64	0.32	0.96	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	96.70	11.04	3.15	1.58	0.53	0.79	0.26
nucleus accumbens, adult, pool1	10037-101F1	234.35	23.62	1.50	0.56	0.47	0.37	0.19
occipital cortex - adult, donor10196	10172-103C1	362.63	30.91	4.12	0.00	8.24	2.06	2.06
occipital cortex, adult, donor10252	10163-103B1	374.10	41.60	8.86	2.42	1.88	1.34	0.00
occipital cortex, newborn, donor10223	10355-105E4	200.53	14.19	1.09	0.73	1.09	0.36	0.36
occipital lobe, adult, donor1	10076-102A4	148.26	13.64	2.10	2.36	1.84	0.79	0.00
occipital lobe, fetal, donor1	10073-102A1	351.43	46.77	3.86	5.15	2.57	3.00	1.72
occipital pole, adult, pool1	10036-101E9	117.95	12.30	0.71	0.16	0.16	0.24	0.24
olfactory region, adult	10195-103E6	220.09	22.16	7.45	2.67	1.15	1.34	0.00
optic nerve, donor1	10277-104E7	272.14	30.02	2.00	2.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	242.97	34.29	1.71	0.80	1.14	1.37	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	267.77	22.81	0.69	0.55	0.55	0.27	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	154.42	15.58	3.22	3.39	2.71	3.05	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	210.92	30.84	2.77	1.85	1.16	2.19	1.16
osteoclastoma cell line:Hs 706.T	10704-109H2	100.54	9.99	1.47	1.18	0.88	0.00	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	434.47	58.86	0.00	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	183.01	29.48	0.42	0.42	0.42	0.21	0.21
ovary, adult, pool1	10020-101D2	287.91	21.05	1.22	0.35	0.35	0.87	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	136.94	19.07	2.20	1.83	1.47	1.83	0.00
pancreas, adult, donor1	10049-101G4	72.43	10.35	1.88	1.88	0.00	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	116.29	15.93	1.12	0.56	0.84	1.40	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	170.69	33.90	5.11	5.62	1.02	3.75	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	263.11	25.50	0.50	0.17	0.50	0.33	0.00
paracentral gyrus, adult, pool1	10035-101E8	209.04	23.80	1.37	0.46	0.37	0.73	0.18
parietal cortex, adult, donor10258	10373-105G4	190.84	15.41	2.94	2.94	0.73	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	268.98	25.39	2.82	2.82	2.82	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	320.10	33.06	7.13	2.57	2.28	1.71	0.00
parietal lobe, adult, pool1	10034-101E7	209.90	22.12	0.62	0.35	0.26	0.44	0.00
parietal lobe, fetal, donor1	10072-101I9	373.39	56.25	9.70	4.85	5.82	2.91	0.97
parietal lobe, newborn, donor10223	10356-105E5	234.04	14.58	1.50	0.37	0.75	1.87	0.00
parotid gland, adult	10199-103F1	101.13	8.02	0.62	0.00	0.00	1.23	0.00
penis, adult	10200-103F2	171.34	15.58	4.30	3.22	2.69	0.54	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	281.69	29.01	5.21	1.86	2.23	0.93	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	86.11	15.30	2.48	0.44	1.02	0.87	0.73
pineal gland - adult, donor10196	10179-103C8	374.12	39.35	1.94	5.81	0.65	0.65	0.65
pineal gland, adult, donor10252	10160-103A7	578.00	62.18	2.96	1.78	1.18	1.18	0.00
pineal gland, adult, donor10258	10377-105G8	269.64	28.22	3.14	1.25	1.25	1.25	0.63
pituitary gland - adult, donor10196	10180-103C9	346.04	29.34	5.06	2.02	0.00	2.02	1.01
pituitary gland, adult, donor10252	10162-103A9	631.67	55.25	4.69	2.08	0.52	2.08	0.00
pituitary gland, adult, donor10258	10378-105G9	200.89	11.92	1.70	3.40	2.55	0.00	0.85
placenta, adult, pool1	10021-101D3	205.76	24.19	0.86	0.86	0.65	0.22	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	227.91	29.00	3.18	3.18	1.59	1.85	1.59
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	138.36	12.61	0.93	0.78	0.00	0.31	0.00
pons, adult, pool1	10033-101E6	252.44	25.99	1.29	0.60	0.34	0.43	0.09
postcentral gyrus, adult, pool1	10032-101E5	144.80	15.69	1.05	0.17	0.52	0.26	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	56.47	14.64	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	126.68	27.54	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	70.41	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	210.34	32.34	0.73	1.60	0.44	1.89	2.04
prostate cancer cell line:PC-3	10439-106E7	360.46	44.10	3.09	2.54	1.45	3.09	1.63
prostate, adult, pool1	10022-101D4	275.61	27.03	1.18	0.54	0.18	0.54	0.09
putamen, adult, donor10196	10176-103C5	262.50	35.17	6.14	2.12	0.94	0.71	0.00
putamen, adult, donor10252	10152-102I8	299.99	23.53	3.92	0.00	0.00	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	608.70	26.23	5.46	4.37	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	185.56	22.23	4.83	1.45	1.69	0.48	0.00
putamen, newborn, donor10223	10365-105F5	525.51	50.23	1.50	0.75	1.50	2.25	0.00
rectal cancer cell line:TT1TKB	10469-106I1	370.07	39.86	0.58	0.87	0.58	0.00	0.29
rectum, fetal, donor1	10067-101I4	180.83	22.26	0.00	0.00	0.00	1.39	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	151.37	17.17	0.64	0.21	0.42	0.64	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	124.26	7.04	2.49	1.24	1.24	1.66	0.00
retina, adult, pool1	10030-101E3	199.10	18.69	1.19	0.40	0.50	0.50	0.10
retinoblastoma cell line:Y79	10475-106I7	490.25	58.72	3.64	2.86	1.30	2.86	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	285.85	43.77	4.30	1.60	0.98	0.61	0.86
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	625.11	86.89	1.12	1.41	1.69	0.84	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	127.32	15.91	0.76	1.52	0.00	1.52	0.00
salivary acinar cells, donor1	11771-123I7	64.26	9.71	1.13	0.16	0.97	0.65	0.65
salivary acinar cells, donor2	11772-123I8	74.21	11.43	1.93	0.83	0.83	0.69	0.83
salivary acinar cells, donor3	11773-123I9	86.07	12.58	1.99	0.00	0.66	0.00	0.66
salivary gland, adult, pool1	10093-102C3	176.73	13.73	0.57	0.57	0.57	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	146.20	12.39	0.51	0.25	0.51	0.34	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	136.60	18.22	1.06	0.24	0.47	0.59	0.47
seminal vesicle, adult	10201-103F3	143.38	19.58	2.12	2.65	4.23	1.59	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	180.98	23.32	2.92	2.67	0.97	1.46	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	120.53	10.82	2.77	1.26	0.50	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	263.93	20.07	3.01	4.01	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	160.11	13.70	4.16	1.61	1.21	1.75	1.61
signet ring carcinoma cell line:Kato III	10436-106E4	181.71	18.35	0.33	0.66	0.22	0.22	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	173.54	21.03	0.39	0.52	0.39	0.00	0.65
skeletal muscle - soleus muscle, donor1	10282-104F3	189.39	11.35	1.42	0.71	1.42	3.55	0.00
skeletal muscle, adult, pool1	10023-101D5	203.65	16.67	0.48	0.36	0.24	0.24	0.00
skeletal muscle, fetal, donor1	10066-101I3	90.45	12.06	1.01	0.00	1.01	1.01	0.00
skin, adult, donor1	10074-102A2	108.56	20.36	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	199.47	28.41	3.79	2.52	4.42	1.89	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	220.13	41.36	2.67	1.67	1.00	0.33	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	370.05	59.89	14.81	7.25	3.15	3.78	4.41
small cell lung carcinoma cell line:DMS 144	10841-111E4	298.95	35.08	4.05	2.31	2.51	1.54	5.01
small cell lung carcinoma cell line:LK-2	10541-107H1	447.67	63.79	1.15	0.66	0.66	0.66	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	526.30	39.09	9.97	6.27	3.22	3.22	2.57
small cell lung carcinoma cell line:WA-hT	10562-108A4	422.11	62.76	6.54	4.14	2.83	4.36	0.65
small intestine, adult, pool1	10024-101D6	264.21	28.31	1.79	0.24	0.24	0.48	0.12
small intestine, fetal, donor1	10064-101I1	161.42	20.64	6.63	3.93	2.21	2.21	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	132.84	10.26	4.62	3.59	0.51	1.54	1.54
smooth muscle, adult, pool1	10048-101G3	263.37	29.46	5.17	1.29	1.81	1.55	0.26
somatostatinoma cell line:QGP-1	10781-110G7	101.04	41.28	1.07	0.27	0.00	0.27	0.27
spinal cord - adult, donor10196	10181-103D1	298.92	30.28	5.28	3.21	3.44	1.84	0.23
spinal cord, adult, donor10252	10159-103A6	589.04	52.44	5.13	1.97	2.76	2.76	0.00
spinal cord, adult, donor10258	10369-105F9	546.52	45.66	4.84	1.38	2.77	1.38	0.69
spinal cord, fetal, donor1	10056-101H2	172.58	25.61	3.66	3.66	2.44	4.88	0.00
spinal cord, newborn, donor10223	10359-105E8	549.68	34.44	2.30	2.76	1.84	1.84	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	131.28	21.36	1.34	0.30	0.45	0.60	0.15
spleen, adult, pool1	10025-101D7	156.72	20.26	0.55	0.22	0.33	0.33	0.00
spleen, fetal, pool1	10044-101F8	153.51	20.98	0.16	0.48	0.16	0.24	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	188.91	24.22	1.14	0.93	1.04	0.41	0.41
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	228.80	21.84	1.14	0.38	0.76	1.52	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	227.49	30.40	10.83	4.19	2.80	4.54	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	164.97	17.98	1.56	0.78	0.39	0.78	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	186.40	26.79	0.90	1.13	0.56	0.34	1.13
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	129.20	11.01	0.42	0.85	1.27	0.42	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	195.04	23.27	0.42	0.42	0.00	0.42	0.00
stomach, fetal, donor1	10062-101H8	126.02	16.02	0.00	0.00	0.00	0.00	1.07
submaxillary gland, adult	10202-103F4	117.92	11.96	2.85	2.85	1.71	3.42	0.00
substantia nigra - adult, donor10196	10178-103C7	1628.22	162.82	0.00	108.55	162.82	108.55	0.00
substantia nigra, adult, donor10252	10158-103A5	358.92	39.05	7.69	2.70	1.25	2.70	0.21
substantia nigra, adult, donor10258	10371-105G2	283.97	17.07	3.10	0.52	0.00	1.03	0.00
substantia nigra, newborn, donor10223	10358-105E7	293.23	11.31	0.71	0.71	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	343.90	40.81	4.81	3.21	2.98	1.60	1.60
temporal lobe, adult, pool1	10031-101E4	112.83	11.70	0.85	0.25	0.08	0.51	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	289.89	54.13	4.27	7.12	2.85	2.14	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	365.26	36.48	8.79	6.59	5.27	2.64	0.00
tenocyte, donor1	11763-123H8	122.19	10.82	7.68	5.59	2.44	0.70	1.05
tenocyte, donor2	11765-123I1	81.26	8.01	6.10	0.00	0.38	1.14	0.00
tenocyte, donor3	11768-123I4	115.28	14.46	7.78	2.97	2.97	3.71	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	309.50	50.99	4.08	2.21	2.21	1.70	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	182.67	19.42	1.23	1.54	0.92	0.92	0.92
teratocarcinoma cell line:PA-1	10807-111A6	286.40	48.04	3.87	2.63	2.17	1.39	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	148.40	26.53	2.16	1.14	0.76	1.02	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	295.73	33.66	1.89	2.65	0.38	0.38	1.89
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	121.17	19.30	0.76	0.55	0.65	0.11	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	225.39	52.44	13.68	8.14	5.21	4.89	0.00
testis, adult, pool1	10026-101D8	155.58	19.54	1.29	0.75	0.21	0.11	0.11
testis, adult, pool2	10096-102C6	195.32	16.24	9.92	11.28	3.61	3.16	0.45
thalamus - adult, donor10196	10168-103B6	409.58	33.12	5.52	2.21	3.31	1.10	0.00
thalamus, adult, donor10252	10154-103A1	445.09	36.26	6.10	5.00	2.19	1.56	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	799.06	7.70	3.08	0.00	4.62	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	87.61	9.55	0.49	0.66	0.33	0.33	0.00
thalamus, newborn, donor10223	10366-105F6	195.03	18.99	0.58	0.58	0.00	0.00	0.00
throat, adult	10209-103G2	144.31	15.98	1.75	3.99	1.50	1.25	0.25
throat, fetal, donor1	10061-101H7	149.31	21.94	3.35	0.61	0.91	1.52	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	248.61	26.03	1.59	1.59	0.79	0.79	1.39
thymus, adult, pool1	10027-101D9	248.54	43.34	1.39	0.50	0.10	0.50	0.20
thymus, fetal, pool1	10043-101F7	309.12	43.85	0.94	0.83	0.62	0.10	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	179.50	20.08	1.86	1.46	0.53	0.80	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	177.69	39.25	4.33	2.65	1.68	2.51	0.98
thyroid, adult, pool1	10028-101E1	333.69	47.12	2.33	0.47	0.47	0.56	0.00
thyroid, fetal, donor1	10060-101H6	168.48	27.68	5.54	2.64	3.16	1.58	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	92.39	9.24	0.00	0.00	3.08	0.00	0.00
tongue, adult	10203-103F5	142.10	13.49	1.40	2.79	1.86	0.47	0.00
tongue, fetal, donor1	10059-101H5	153.30	22.07	1.58	1.97	1.58	1.58	0.00
tonsil, adult, pool1	10047-101G2	165.09	15.53	0.20	0.20	0.00	0.40	0.10
trachea, adult, pool1	10029-101E2	178.57	20.45	0.98	0.33	0.08	0.82	0.00
trachea, fetal, donor1	10058-101H4	152.34	18.08	3.46	1.92	0.00	0.77	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	130.02	17.71	3.90	1.77	1.77	1.77	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	332.52	37.99	0.81	0.71	0.41	0.20	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	255.40	32.90	1.41	1.25	0.47	0.78	2.66
tridermal teratoma cell line:HGRT	10694-109G1	136.98	24.73	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	136.20	19.72	2.29	1.10	0.59	0.42	0.25
umbilical cord, fetal, donor1	10057-101H3	135.62	14.61	4.17	2.09	0.00	2.09	2.09
uterus, adult, pool1	10100-102D1	387.16	26.28	2.56	0.34	0.00	0.68	0.00
uterus, fetal, donor1	10055-101H1	228.83	31.74	3.58	1.02	1.54	1.54	0.00
vagina, adult	10204-103F6	353.47	28.43	5.82	0.00	0.00	0.65	0.00
vein, adult	10191-103E2	135.68	15.78	0.66	1.97	0.88	0.88	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	98.80	12.02	2.14	1.34	0.27	0.80	0.80